var title_f14_33_14864="Contents: Gynecologic oncology";
var content_f14_33_14864=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?6/40/6798\">",
"       Obstetrics, Gynecology and Women's Health",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Gynecologic oncology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Gynecologic oncology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Cervical cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/54/37736\">",
"           Cervical adenocarcinoma in situ",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/42/6826\">",
"           Cervical cancer in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/3/8248\">",
"           Cervical cancer screening tests: Evidence of effectiveness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/32/35337\">",
"           Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/36/25156\">",
"           Cervical cancer screening tests: Visual inspection methods",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/25/9624\">",
"           Cervical cytology: Evaluation of atypical and malignant glandular cells",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/6/33895\">",
"           Cervical cytology: Evaluation of atypical squamous cells (ASC-US and ASC-H)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/54/28517\">",
"           Cervical cytology: Evaluation of high grade squamous intraepithelial lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/60/6086\">",
"           Cervical cytology: Evaluation of low grade squamous intraepithelial lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/15/40185\">",
"           Cervical cytology: Interpretation of results",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/19/44343\">",
"           Cervical intraepithelial neoplasia: Ablative therapies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/21/31065\">",
"           Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/2/30762\">",
"           Cervical intraepithelial neoplasia: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/17/33048\">",
"           Cervical intraepithelial neoplasia: Procedures for cervical conization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/52/16200\">",
"           Cervical intraepithelial neoplasia: Reproductive effects of treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/42/9898\">",
"           Fertility sparing surgery for invasive cervical cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/49/6938\">",
"           Invasive cervical adenocarcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/55/28537\">",
"           Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/42/17064\">",
"           Invasive cervical cancer: Patterns of recurrence and posttreatment surveillance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/21/21849\">",
"           Invasive cervical cancer: Staging and evaluation of lymph nodes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/22/4455\">",
"           Laparoscopic pelvic and paraaortic lymphadenectomy in gynecologic cancers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/14/9449\">",
"           Management of early stage cervical cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/50/7976\">",
"           Management of locally advanced cervical cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/37/33368\">",
"           Management of recurrent or metastatic cervical cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/14/18665\">",
"           Preinvasive and invasive cervical neoplasia in HIV-infected women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/4/36934\">",
"           Screening for cervical cancer in HIV infected women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/45/19160\">",
"           Screening for cervical cancer in resource-limited settings",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/16/38154\">",
"           Screening for cervical cancer: Rationale and recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/23/5498\">",
"           Small cell neuroendocrine carcinoma of the cervix",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/53/26455\">",
"           Virology of human papillomavirus infections and the link to cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fallopian tube cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/25/34202\">",
"           Risk-reducing bilateral salpingo-oophorectomy in women at high risk of epithelial ovarian and fallopian tubal cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/15/40185\">",
"           Cervical cytology: Interpretation of results",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/8/131\">",
"           Endometrial sampling procedures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/60/31689\">",
"           Exenteration for gynecologic cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/26/37285\">",
"           Heavy or irregular uterine bleeding during chemotherapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/22/4455\">",
"           Laparoscopic pelvic and paraaortic lymphadenectomy in gynecologic cancers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/2/22570\">",
"           Overview of radiation therapy for gynecologic malignancies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gestational trophoblastic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/11/24761\">",
"           Gestational trophoblastic disease: Epidemiology, clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/30/23015\">",
"           Gestational trophoblastic disease: Management of hydatidiform mole",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/31/13816\">",
"           Gestational trophoblastic disease: Pathology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/15/42234\">",
"           Gestational trophoblastic neoplasia: Staging and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/1/39960\">",
"           Human chorionic gonadotropin testing",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ovarian cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/39/26231\">",
"           Adjuvant therapy of early stage (stage I and II) epithelial ovarian, fallopian tubal, or peritoneal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/1/24601\">",
"           Approach to the patient with an adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/53/19287\">",
"           Chemotherapy of ovarian cancer in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/62/9192\">",
"           Clinical manifestations and diagnosis of ovarian cancer in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/57/19352\">",
"           Differential diagnosis of the adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/23/23927\">",
"           Early detection of epithelial ovarian cancer: Role of symptom recognition",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/51/18233\">",
"           Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/6/31849\">",
"           Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/23/25978\">",
"           Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Epidemiology and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/48/36618\">",
"           Epithelial ovarian cancer: Initial surgical management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/52/17224\">",
"           Epithelial ovarian cancer: Pathology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/15/25847\">",
"           Epithelial ovarian cancer: Second look surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/11/21689\">",
"           First-line chemotherapy for advanced (stage III or IV) epithelial ovarian, fallopian tubal, and peritoneal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/33/537\">",
"           Intraperitoneal chemotherapy for treatment of ovarian cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/63/39928\">",
"           Malignancy-related ascites",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/11/30905\">",
"           Management of an adnexal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/41/4759\">",
"           Management of ovarian cancer in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/17/29977\">",
"           Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-resistant disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/21/37209\">",
"           Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-sensitive disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/57/24472\">",
"           Neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/37/5721\">",
"           Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/0/5128\">",
"           Ovarian tumors of low malignant potential",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/31/5624\">",
"           Overview of epithelial carcinoma of the ovary, fallopian tube, and peritoneum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/45/16087\">",
"           Overview of sex cord-stromal tumors of the ovary",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/26/28073\">",
"           Pathogenesis of ovarian, fallopian tubal, and peritoneal serous carcinomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/25/34202\">",
"           Risk-reducing bilateral salpingo-oophorectomy in women at high risk of epithelial ovarian and fallopian tubal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/14/10474\">",
"           Screening for ovarian cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/16/33033\">",
"           Serum biomarkers for evaluation of an adnexal mass for epithelial carcinoma of the ovary, fallopian tube, or peritoneum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/36/8778\">",
"           Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/22/12646\">",
"           Sex cord-stromal tumors of the ovary: Sertoli-stromal cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/9/32916\">",
"           Sex cord-stromal tumors of the ovary: Tumors with granulosa and Sertoli-Leydig elements",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/40/34440\">",
"           Sonographic differentiation of benign versus malignant adnexal masses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/30/13799\">",
"           Struma ovarii",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/26/28070\">",
"           Surgery for recurrent epithelial ovarian cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/35/11832\">",
"           The role of angiogenesis inhibitors in epithelial carcinoma of the ovary, fallopian tube, or peritoneum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/24/33162\">",
"           Treatment of malignant germ cell tumors of the ovary",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Uterine cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/0/41991\">",
"           Adjuvant treatment of high-risk endometrial cancers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/62/13287\">",
"           Adjuvant treatment of intermediate-risk endometrial cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/41/8855\">",
"           Approach to adjuvant treatment of endometrial cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/58/26535\">",
"           Classification and diagnosis of endometrial hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/34/44585\">",
"           Clinical features, diagnosis, staging, and treatment of uterine carcinosarcoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/51/18233\">",
"           Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/6/37992\">",
"           Endometrial carcinoma: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/27/18874\">",
"           Endometrial carcinoma: Epidemiology and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/7/36983\">",
"           Endometrial carcinoma: Histopathology and pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/23/18810\">",
"           Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/53/38744\">",
"           Evaluation of the endometrium for malignant or premalignant disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/22/4455\">",
"           Laparoscopic pelvic and paraaortic lymphadenectomy in gynecologic cancers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/3/37943\">",
"           Management of endometrial hyperplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/7/21624\">",
"           Overview of endometrial carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/57/15257\">",
"           Treatment and prognosis of uterine leiomyosarcoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/18/22825\">",
"           Treatment of locally advanced, recurrent, or metastatic endometrial cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/23/7542\">",
"           Treatment of low-risk endometrial cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/3/22584\">",
"           Type II endometrial carcinomas (eg, serous, clear cell, mucinous)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/22/2408\">",
"           Uterine sarcoma: Classification, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/3/17465\">",
"           Variants of uterine leiomyomas (fibroids)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Vaginal cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/30/31208\">",
"           Vaginal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/27/5560\">",
"           Vaginal intraepithelial neoplasia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Vulvar cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/19/6455\">",
"           Vulvar and vaginal intraepithelial neoplasia in HIV-infected women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/5/9303\">",
"           Vulvar cancer: Clinical manifestations, diagnosis, and pathology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/14/20714\">",
"           Vulvar cancer: Staging, treatment, and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/11/32952\">",
"           Vulvar intraepithelial neoplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/12/14535\">",
"           Vulvar wide local excision, simple vulvectomy, and skinning vulvectomy",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-8094266DD3-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f14_33_14864=[""].join("\n");
var outline_f14_33_14864=null;
var title_f14_33_14865="Sulfa crystals";
var content_f14_33_14865=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F56708&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F56708&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Photomicrograph showing urine sediment of a patient with sulfonamide crystalluria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Urine sediment showing sulfonamide crystals with a needle-shaped appearance. Other forms that may be seen include rosettes and a shock of wheat appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harvard Medical School.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14865=[""].join("\n");
var outline_f14_33_14865=null;
var title_f14_33_14866="Overview of the surgery of deceased donor renal transplantation";
var content_f14_33_14866=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the surgery of deceased donor renal transplantation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/33/14866/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14866/contributors\">",
"     Ron Shapiro, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/33/14866/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14866/contributors\">",
"     Daniel C Brennan, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/33/14866/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14866/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/33/14866/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal transplantation is the most commonly performed vascularized solid organ transplant. Technically, it is perhaps the easiest transplant procedure to perform, and has the added security of the ability to provide dialysis in patients who experience delayed allograft function [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14866/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. However, it is unforgiving of technical error, and can present specific challenges in the case of particular recipient or donor issues.",
"   </p>",
"   <p>",
"    The basic elements of backtable preparation of the deceased donor kidney and the features of implantation in adults and children will be discussed here. The complications associated with this procedure are presented separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKTABLE PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomic structures that are transplanted during a deceased donor kidney transplant usually consist of the kidney, with most of the perinephric fat removed, and the following anatomic structures:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Renal artery(ies), usually with a cuff of the donor aorta",
"     </li>",
"     <li>",
"      Renal vein(s), usually with a cuff of the inferior vena cava for the left kidney or the entire inferior vena cava for the right kidney",
"     </li>",
"     <li>",
"      Ureter with a generous amount of peri-ureteral tissue.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The kidney is immersed in an iced saline or Ringer's Lactate solution while being prepared for implantation. The renal vein is dissected free, and its branches (on the left side, the adrenal, gonadal, and lumbar) are ligated. The artery is then dissected free. The excess perinephric fat is removed, and the remaining tissue is ligated. Relatively little dissection of the ureter is performed in order to minimize the risk of devascularization. To allow for efficient vascular anastomosis, the excess vena cava and aorta are trimmed.",
"   </p>",
"   <p>",
"    With a right kidney, the short renal vein can be extended using the donor vena cava or iliac vein; this results in a longer vein for easier implantation, minimizing the disparity in length between the renal artery and vein. Therefore, the artery does not become kinked.",
"   </p>",
"   <p>",
"    In the case of variations, such as multiple (or inadvertently transected) arteries, back table reconstruction may be needed to facilitate implantation. There is no collateral arterial circulation to the kidney, so the entire arterial supply must be revascularized. By comparison, there is excellent collateral venous drainage, so a second renal vein can be ligated with impunity.",
"   </p>",
"   <p>",
"    With a kidney from a living donor, recovered using the open technique, much of the preparation of the kidney has been done in situ prior to the recovery of the organ; laparoscopically-recovered living donor kidneys are actually more similar to deceased donor kidneys and require much more back table preparation. The donor artery and vein will be shorter than with a deceased donor kidney, as the donor vena cava and aorta are obviously not available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     IMPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to the transplanted heart, lung, and liver, which are transplanted orthotopically, the kidney is transplanted heterotopically, usually into the iliac fossa. The native kidneys are rarely removed.",
"   </p>",
"   <p>",
"    A potential retroperitoneal space is created by making a right (or left) lower quadrant incision. The inferior epigastric vessels and lymphatics are ligated and divided, and, in women, the round ligament is divided; in men, the spermatic cord is usually preserved. The peritoneum is mobilized medially to expose the external iliac artery and vein, which are then dissected free.",
"   </p>",
"   <p>",
"    The renal vein is usually anastomosed first, end-to-side to the external iliac vein, with a running 5-0 or 6-0 polypropylene suture. The renal artery is usually anastomosed end-to-side to the external iliac artery, again with a running 5-0 or 6-0 polypropylene suture.",
"   </p>",
"   <p>",
"    During the exposure of the vessels, the recipient is hydrated; in addition,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    1",
"    <span class=\"nowrap\">",
"     gm/kg",
"    </span>",
"    are infused slowly as the vessels are anastomosed. The kidney can be kept cold during the implantation by being wrapped in an ice blanket. The living donor kidney is kept cool by topical irrigation with cold saline.",
"   </p>",
"   <p>",
"    After reperfusion of the kidney, bleeding vessels are identified and ligated, oversewn, or cauterized. The ureter is then implanted into the bladder, usually with an extravesical technique, with a slowly absorbable suture, such as 6-0 polyglyconate (Maxon&reg;) or polydioxanone (PDS&reg;). Some surgeons prefer to stent the ureteroneocystostomy to minimize the risk of leak or stenosis. When a stent is used (a personal preference is six french 12 cm double J stent, but there are other options), it is generally left in place for four to six weeks and is removed cystoscopically. Others tie a suture to the stent and Foley catheter and the stent and catheter are removed at discharge from the hospital.",
"   </p>",
"   <p>",
"    There are a number of potential variations regarding the technical aspects of implantation, but the basic principles of venous, arterial, and ureteral anastomosis are common to any kidney transplantation.",
"   </p>",
"   <p>",
"    In small pediatric recipients weighing less than 20 kg, the external iliac vessels are usually too small to allow for implantation. The important principle is to identify appropriately-sized vessels; in the smallest recipients, this may require intra-abdominal exposure and anastomosis to the recipient aorta and vena cava to allow adequate inflow and outflow. Of additional critical importance is the need to overhydrate the very small pediatric recipient, to ensure adequate renal perfusion, as the transplanted kidney may take up a substantial percentage of the recipient's cardiac output. It is also important to either fix the kidney to the retroperitoneum",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abdominal wall or put the kidney in at least a partially retroperitoneal position by draping the right colon over it, in order to minimize the risk of subsequent torsion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26033591\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Renal transplantation is the most commonly performed vascularized solid organ transplant. Although it is technically perhaps the easiest transplant procedure to perform, it is unforgiving of technical error, and can present specific challenges in the case of particular recipient or donor issues. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The anatomic structures that are transplanted during a deceased donor kidney transplant consist of the kidney, with most of the perinephric fat removed, renal arteries, renal veins, and ureter. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Backtable preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are a number of potential variations regarding the technical aspects of implantation, but the basic principles of venous, arterial, and ureteral anastomosis are common to any kidney transplantation. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Implantation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Shapiro, R. Chapter 6, The Transplant Procedure. In: Renal Transplantation, Shapiro, R, Simmons, RL, Starzl, TE (Eds), Appleton &amp; Lange, Stamford, CT 1998.",
"    </li>",
"    <li>",
"     Ellis, D, Gilboa, N, Bellinger, M, Shapiro, R. Chapter 14, Renal Transplantation in Infants and Children. In: Renal Transplantation, Shapiro, R, Simmons, RL, Starzl, TE (Eds), Appleton &amp; Lange, Stamford, CT 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14866/abstract/3\">",
"      Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor. N Engl J Med 2004; 351:2730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14866/abstract/4\">",
"      Humar A, Matas AJ. Surgical complications after kidney transplantation. Semin Dial 2005; 18:505.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7322 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-A0D016103C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14866=[""].join("\n");
var outline_f14_33_14866=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26033591\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKTABLE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      IMPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26033591\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_33_14867="Patient information: Hip fracture (The Basics)";
var content_f14_33_14867=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/82818\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/48/3841\">",
"         Hip",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/43/17073\">",
"          Hip replacement prosthesis",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/13/18647\">",
"           Foods and drinks with calcium and vitamin D",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?23/6/23650\">",
"         Patient information: Bone density testing (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/12/36034\">",
"         Patient information: Calcium and vitamin D for bone health (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/34/30243\">",
"         Patient information: Fractures (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?22/34/23075\">",
"         Patient information: Hip replacement (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/58/35746\">",
"         Patient information: Osteoporosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?5/21/5459\">",
"         Patient information: Pelvic fracture (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/53/39761\">",
"         Patient information: Pressure sores (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?41/4/42050\">",
"         Patient information: Preventing falls (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/46/18146\">",
"         Patient information: Quitting smoking (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?1/29/1491\">",
"         Patient information: Bone density testing (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?22/60/23491\">",
"         Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/49/25366\">",
"         Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/13/19670\">",
"         Patient information: Quitting smoking (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/30/21987\">",
"         Patient information: Total hip replacement (arthroplasty) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Hip fracture (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/hip-fracture-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H16484033\">",
"      <span class=\"h1\">",
"       What is a hip fracture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A &ldquo;fracture&rdquo; is another word for a broken bone. A hip fracture is when a person breaks the top of the thigh bone (femur) near the hip joint (",
"      <a class=\"graphic graphic_figure graphicRef82793 \" href=\"UTD.htm?3/48/3841\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      There are different types of hip fractures. The type of hip fracture depends on which part of the thigh bone breaks and how it breaks.",
"     </p>",
"     <p>",
"      Hip fractures are usually caused by falls. Hip fractures happen most often in older adults, especially those with a disease that makes the bones weak, called osteoporosis.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16484048\">",
"      <span class=\"h1\">",
"       What are the symptoms of a hip fracture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms of a hip fracture include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain in the hip or groin",
"       </li>",
"       <li>",
"        Being unable to walk",
"       </li>",
"       <li>",
"        Swelling",
"       </li>",
"       <li>",
"        Bruising",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      A hip fracture can also make the injured leg look like it&rsquo;s turned away from the body and shorter than the uninjured leg.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16484063\">",
"      <span class=\"h1\">",
"       Is there a test for a hip fracture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The doctor or nurse will ask about your injury and symptoms, do an exam, and order an X-ray.",
"     </p>",
"     <p>",
"      Some people need an imaging test called an MRI scan. Imaging tests create pictures of the inside of the body.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16484078\">",
"      <span class=\"h1\">",
"       How are hip fractures treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;First, your doctor will treat your pain. Doctors can use different medicines to treat pain. The medicines can come as a shot, pill, or go into your vein through a tube called an &ldquo;IV.&rdquo;",
"     </p>",
"     <p>",
"      Then most people with a hip fracture are treated with surgery. People usually have surgery within a few days of their injury. Doctors can use 2 main types of surgery to treat a hip fracture, depending on the type of fracture.",
"     </p>",
"     <p>",
"      In one type of surgery, the doctor puts screws, pins, rods, or plates inside the body to fix the fracture.",
"     </p>",
"     <p>",
"      The other type of surgery used to treat a hip fracture is a hip replacement. During this surgery, the doctor replaces a person&rsquo;s hip joint with a man-made hip joint (",
"      <a class=\"graphic graphic_figure graphicRef65030 \" href=\"UTD.htm?16/43/17073\">",
"       figure 2",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      After surgery, you will work with a physical therapist (exercise expert). He or she will teach you exercises to make the muscles around your hip stronger. He or she will work with you on bending, walking, and climbing stairs so you can move normally.",
"     </p>",
"     <p>",
"      In some cases, hip fractures are not treated with surgery. For instance, people who have a mild fracture and are still able to walk might not need surgery. Their fracture will heal on its own.",
"     </p>",
"     <p>",
"      After your hip fracture, your doctor will probably test you for osteoporosis. This involves a special X-ray called a bone density test. Your doctor might also treat you for osteoporosis. Treatment for osteoporosis usually involves medicines called bisphosphonates.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16484093\">",
"      <span class=\"h1\">",
"       How long do hip fractures take to heal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Hip fractures take weeks to months to heal, depending on the type of fracture.",
"     </p>",
"     <p>",
"      Healing time also depends on the person. Healthy children usually heal much more quickly than older adults or adults with other medical problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16484108\">",
"      <span class=\"h1\">",
"       Can I do anything to improve the healing process?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. It&rsquo;s important to follow all of your doctor&rsquo;s instructions while your hip fracture is healing. Plus, your doctor will probably recommend that you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Eat a healthy diet that includes getting enough calcium, vitamin D, and protein (",
"        <a class=\"graphic graphic_figure graphicRef79375 \" href=\"UTD.htm?18/13/18647\">",
"         figure 3",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Stop smoking. A fracture can take longer to heal if you smoke.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16484123\">",
"      <span class=\"h1\">",
"       When should I call my doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After treatment, your doctor or nurse will tell you when to call him or her. In general, you should call him or her if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        You get a fever.",
"       </li>",
"       <li>",
"        You have severe pain, or your pain or swelling gets worse.",
"       </li>",
"       <li>",
"        Your leg gets swollen or you see red streaks on your leg.",
"       </li>",
"       <li>",
"        You have chest pain, trouble breathing, or dizziness.",
"       </li>",
"       <li>",
"        Fluid or pus drains out of the cut from your surgery.",
"       </li>",
"       <li>",
"        You get an open sore on your skin.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16484138\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/21/5459?source=see_link\">",
"       Patient information: Pelvic fracture (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30243?source=see_link\">",
"       Patient information: Fractures (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=see_link\">",
"       Patient information: Osteoporosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/34/23075?source=see_link\">",
"       Patient information: Hip replacement (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/6/23650?source=see_link\">",
"       Patient information: Bone density testing (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/4/42050?source=see_link\">",
"       Patient information: Preventing falls (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=see_link\">",
"       Patient information: Quitting smoking (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/53/39761?source=see_link\">",
"       Patient information: Pressure sores (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/30/21987?source=see_link\">",
"       Patient information: Total hip replacement (arthroplasty) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"       Patient information: Quitting smoking (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=see_link\">",
"       Patient information: Bone density testing (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=see_link\">",
"       Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?14/33/14867?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82818 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-7D7969DF47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14867=[""].join("\n");
var outline_f14_33_14867=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16484033\">",
"      What is a hip fracture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16484048\">",
"      What are the symptoms of a hip fracture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16484063\">",
"      Is there a test for a hip fracture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16484078\">",
"      How are hip fractures treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16484093\">",
"      How long do hip fractures take to heal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16484108\">",
"      Can I do anything to improve the healing process?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16484123\">",
"      When should I call my doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16484138\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/82818\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/48/3841\">",
"      Hip",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/43/17073\">",
"       Hip replacement prosthesis",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/13/18647\">",
"        Foods and drinks with calcium and vitamin D",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=related_link\">",
"      Patient information: Bone density testing (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/6/23650?source=related_link\">",
"      Patient information: Bone density testing (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30243?source=related_link\">",
"      Patient information: Fractures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/34/23075?source=related_link\">",
"      Patient information: Hip replacement (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=related_link\">",
"      Patient information: Osteoporosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=related_link\">",
"      Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/21/5459?source=related_link\">",
"      Patient information: Pelvic fracture (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/53/39761?source=related_link\">",
"      Patient information: Pressure sores (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/4/42050?source=related_link\">",
"      Patient information: Preventing falls (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=related_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=related_link\">",
"      Patient information: Quitting smoking (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/30/21987?source=related_link\">",
"      Patient information: Total hip replacement (arthroplasty) (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_33_14868="Melanoma in atypical nevus 2";
var content_f14_33_14868=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Melanoma arising in atypical nevus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14868=[""].join("\n");
var outline_f14_33_14868=null;
var title_f14_33_14869="Pseudoephedrine and codeine: Patient drug information";
var content_f14_33_14869=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Pseudoephedrine and codeine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/8/7302?source=see_link\">",
"     see \"Pseudoephedrine and codeine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6808425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Codar&reg; D;",
"     </li>",
"     <li>",
"      EndaCof-DC;",
"     </li>",
"     <li>",
"      Notuss&reg;-DC",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10017962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691646",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop coughing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691980",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat nose stuffiness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017963\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to pseudoephedrine, codeine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703824",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have very bad heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an enlarged prostate, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697679",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is not for coughs due to smoking or lung disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017969\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017971\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694286",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (solution) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017973\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12194 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A20BFA4EA1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14869=[""].join("\n");
var outline_f14_33_14869=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6808425\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017962\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017964\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017963\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017968\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017969\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017971\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017966\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017967\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017972\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017973\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?7/8/7302?source=related_link\">",
"      Pseudoephedrine and codeine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_33_14870="Morphine sulfate: Patient drug information";
var content_f14_33_14870=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Morphine sulfate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     see \"Morphine sulfate: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     see \"Morphine sulfate: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8776636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Astramorph/PF&trade;;",
"     </li>",
"     <li>",
"      AVINza&reg;;",
"     </li>",
"     <li>",
"      Duramorph;",
"     </li>",
"     <li>",
"      Infumorph 200;",
"     </li>",
"     <li>",
"      Infumorph 500;",
"     </li>",
"     <li>",
"      Kadian&reg;;",
"     </li>",
"     <li>",
"      MS Contin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8776637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Doloral;",
"     </li>",
"     <li>",
"      Kadian&reg;;",
"     </li>",
"     <li>",
"      M-Eslon&reg;;",
"     </li>",
"     <li>",
"      M.O.S.-SR&reg;;",
"     </li>",
"     <li>",
"      M.O.S.-Sulfate&reg;;",
"     </li>",
"     <li>",
"      M.O.S.&reg; 10;",
"     </li>",
"     <li>",
"      M.O.S.&reg; 20;",
"     </li>",
"     <li>",
"      M.O.S.&reg; 30;",
"     </li>",
"     <li>",
"      Morphine Extra Forte Injection;",
"     </li>",
"     <li>",
"      Morphine Forte Injection;",
"     </li>",
"     <li>",
"      Morphine HP&reg;;",
"     </li>",
"     <li>",
"      Morphine LP&reg; Epidural;",
"     </li>",
"     <li>",
"      Morphine SR;",
"     </li>",
"     <li>",
"      Morphine-EPD;",
"     </li>",
"     <li>",
"      MS Contin SRT;",
"     </li>",
"     <li>",
"      MS Contin&reg;;",
"     </li>",
"     <li>",
"      MS-IR&reg;;",
"     </li>",
"     <li>",
"      Novo-Morphine SR;",
"     </li>",
"     <li>",
"      PMS-Morphine Sulfate SR;",
"     </li>",
"     <li>",
"      ratio-Morphine;",
"     </li>",
"     <li>",
"      ratio-Morphine SR;",
"     </li>",
"     <li>",
"      Sandoz-Morphine SR;",
"     </li>",
"     <li>",
"      Statex&reg;;",
"     </li>",
"     <li>",
"      Teva-Morphine SR",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700435",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will be watched closely to make sure you do not misuse, abuse, or become addicted to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4090003",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may slow down your breathing too much. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take Avinza&reg; with beer, wine, mixed drinks, or products that have alcohol in them. Very bad effects may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700864",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will be closely watched by your doctor while getting Duramorph&reg;. Unsafe effects may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700242",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not chew or crush long-acting capsules or tablets. Very bad effects may happen if you inject or take chewed or crushed long-acting capsules or tablets. Do not use long-acting products for fast pain relief or on an as needed basis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4014972",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep away from children. Accidental exposure may cause death.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024291\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702551",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to morphine sulfate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703297",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Asthma, raised pressure in the brain, bowel block, or lung disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697135",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a history of a drug or drinking problem, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an enlarged prostate, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before you use other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Poor pain control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3927405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug with other strong pain drugs or if you are using a pain patch without talking to your doctor first.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694792",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use long-acting products for fast pain relief or on an as needed basis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696314",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may sprinkle contents of Kadian&reg; or Avinza&reg; capsule on soft food or liquid. Do not chew.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694286",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (solution) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695332",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Make sure you have the right liquid; there is more than one strength.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705867",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Measure liquid doses carefully. Use the measuring device that comes with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696199",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use suppository rectally.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a pain diary.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle, vein, or into the fatty part of the skin.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699548",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store suppositories in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699657",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any unused drug by flushing down a toilet or sink.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024300\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12261 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-125.39.66.146-C1CFDD43C6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14870=[""].join("\n");
var outline_f14_33_14870=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8776636\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8776637\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024289\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024291\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024290\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024295\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024296\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024298\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024293\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024294\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024299\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024300\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=related_link\">",
"      Morphine sulfate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=related_link\">",
"      Morphine sulfate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_33_14871="Corticotropin injection gel: Pediatric drug information";
var content_f14_33_14871=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Corticotropin injection gel: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?1/62/2023?source=see_link\">",
"    see \"Corticotropin injection gel: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?1/48/1798?source=see_link\">",
"    see \"Corticotropin injection gel: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F154674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      H.P. Acthar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1051916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Adrenal Corticosteroid",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Infantile Spasms, Treatment",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1051908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/62/2023?source=see_link\">",
"      see \"Corticotropin injection gel: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Sudden withdrawal may lead to adrenal insufficiency or recurrent symptoms; tapering the dose prior to discontinuation of therapy may be necessary following prolonged administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants, Children, and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children &lt;2 years:",
"     <b>",
"      Infantile spasms:",
"     </b>",
"     Various regimens have been used; optimal dose and duration of treatment are not established (Go, 2012; Mackey, 2004; Pellock, 2010). Some neurologists recommend low-dose ACTH (5-40 units/day) for short periods (1-6 weeks), while others recommend larger doses of ACTH (40-160 units/day) for long periods of treatment (3-12 months); current guidelines recommend consideration to a low-dose ACTH regimen (as an alternative to high-dose); however, literature suggests that the two dosing regimens are probably equally effective for short-term treatment (Go, 2012); a recent U.S. consensus report recommends short duration (~2 weeks), followed by a taper (Pellock, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Manufacturer labeling: I.M.: 75 units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose twice daily for 2 weeks, followed by a 2-week taper: 30 units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily in the morning for 3 days, followed by 15 units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily in the morning for 3 days, followed by 10 units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily in the morning for 3 days and 10 units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose every other morning for 6 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Alternative dosing: I.M.: A prospective, single-blind study (Hrachovy, 1994) found no major difference in effectiveness between high-dose long-duration versus low-dose short-duration ACTH therapy. Hypertension, however, occurred more frequently in the high-dose group. Further studies comparing long-term outcomes are needed. Low-dose regimen used in this study: Initial: 20 units/day for 2 weeks, if patient responds, taper and discontinue over a 1-week period; if patient does not respond, increase dose to 30 units/day for 4 weeks then taper and discontinue over a 1-week period.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;2 years and Adolescents:",
"     <b>",
"      Anti-inflammatory/immunosuppression:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Manufacturer labeling: I.M., SubQ: 40-80 units/dose every 24-72 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Alternative dosing: I.M.: 0.8 units/kg/",
"     <b>",
"      day or",
"     </b>",
"     25 units/m",
"     <sup>",
"      2",
"     </sup>",
"     /",
"     <b>",
"      day",
"     </b>",
"     divided every 12-24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Acute exacerbation of multiple sclerosis:",
"     </b>",
"     I.M., SubQ: 80-120 units/",
"     <b>",
"      day",
"     </b>",
"     for 2-3 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      All other indications:",
"     </b>",
"     I.M., SubQ: 40-80 units/dose every 24-72 hours",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F154666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, gel:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     H.P. Acthar&reg;: 80 units/mL (5 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F154653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11256533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     H.P. Acthar&reg; Gel is only available through specialty pharmacy distribution and not through traditional distribution sources (eg, wholesalers, retail pharmacies).  Hospitals wishing to acquire H.P. Acthar&reg; Gel should contact CuraScript Specialty Distribution (1-877-599-7748).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     After treatment is initiated, discharge or outpatient prescriptions should be submitted to the Acthar Support and Access Program (A.S.A.P.) in order to ensure an uninterrupted supply of the medication. The Acthar Referral/Prescription form is available online at file://www.acthar.com/files/Acthar-Prescription-Referral-Form.pdf.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Additional information is available for the A.S.A.P. at  file://www.acthar.com/healthcare-professionals/physician-patient-referrals or by calling 1-888-435-2284.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F10961087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1051919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Warm gel before administration; do not over-pressurize vial when withdrawing product. May be administered I.M. or SubQ;  I.M. route is recommended for the treatment of infantile spasms; do not administer I.V.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1051912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store in the refrigerator at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1051918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of infantile spasms as monotherapy (FDA approved in ages &lt;2 years); treatment of acute exacerbations of multiple sclerosis (FDA approved in adults); adjunctive therapy for exacerbations/acute episodes of rheumatic disorders (eg, psoriatic arthritis, rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis) (FDA approved in ages &gt;2 years and adults); exacerbations or maintenance therapy for collagen diseases (eg, systemic lupus erythematosus, systemic dermatomyositis) (FDA approved in ages &gt;2 years and adults); treatment of dermatologic (severe erythema multiforme, Stevens-Johnson syndrome) and allergic (serum sickness) states (FDA approved in ages &gt;2 years and adults); treatment of severe acute/chronic allergic and inflammatory ophthalmic disease (eg, keratitis, iritis, iridocyclitis, diffuse posterior uveitis and choroiditis, optic neuritis, chorioretinitis, anterior segment inflammation) and symptomatic sarcoidosis (FDA approved in ages &gt;2 years and adults); to induce diuresis or remission of proteinuria in patients with nephrotic syndrome without idiopathic uremia or due to lupus erythematosus  (FDA approved in ages &gt;2 years and adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F3296141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Corticotropin may be confused with corticorelin, cosyntropin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F154692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adverse events associated with cortisol elevation; frequency not defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Blood pressure increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Behavioral changes, mood changes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Fluid retention, glucose intolerance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Appetite increased, weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Adverse events associated with infantile spasm treatment:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Cardiovascular: Cardiac hypertrophy, hypertension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Central nervous system: Irritability, pyrexia, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Endocrine &amp; metabolic: Cushingoid syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Gastrointestinal: Appetite decreased, diarrhea, vomiting, weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Respiratory: Nasal congestion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Miscellaneous: Infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Postmarketing and/or case reports (other adverse events associated with corticosteroids may also occur): Abdominal distension, allergic reactions, carbohydrate intolerance (infants), congestive heart failure, diaphoresis (adults), facial erythema, headache (adults), hirsutism, hypokalemic alkalosis (infants), intracranial hemorrhage (adults), muscle weakness, necrotizing angiitis (adults), pancreatitis (adults), reversible brain shrinkage (secondary to hypertension; infants), skin thinning (adults), subdural hematoma, ulcerative esophagitis, vertebral compression fractures (infants), vertigo (adults)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1051923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to corticotropin, porcine proteins, or any component; scleroderma, osteoporosis, systemic fungal infections, ocular herpes simplex, peptic ulcer, uncontrolled hypertension, CHF; recent surgery; primary adrenocortical insufficiency; adrenocortical hyperfunction; infants with suspected congenital infections; concomitant administration of live or live attenuated vaccines; intravenous administration",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1051907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid using higher than recommended doses; suppression of HPA function, suppression of linear growth (ie, reduction of growth velocity), reduced bone mineral density, hypercorticism (Cushing's syndrome), hyperglycemia, or glucosuria may occur; titrate to lowest effective dose. Reduction in growth velocity may occur when corticosteroids or corticotropin are administered to pediatric patients by any route (monitor growth). Use with extreme caution in patients with respiratory tuberculosis or untreated systemic infections. Use with caution in patients with controlled hypertension or renal impairment; long-term use has been associated with fluid retention, increased excretion of potassium and calcium, and hypertension. Use with caution in patients with GI diseases (diverticulitis, peptic ulcer, ulcerative colitis) due to risk of GI bleeding and perforation. Use with caution in patients with myasthenia gravis; exacerbation of symptoms has occurred, especially during initial treatment with corticosteroids. Use with caution in patients with hepatic impairment, including cirrhosis; enhanced pharmacologic effect due to decreased metabolism and long-term use has been associated with fluid retention.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use with caution in patients with diabetes; corticosteroids may alter glucose regulation, leading to hyperglycemia. Use with caution in patients with cataracts and/or glaucoma; increased intraocular pressure, open-angle glaucoma, and cataracts have occurred with prolonged use; consider routine eye exams in chronic users. Use with caution in patients with a history of seizure disorder; seizures have been reported with adrenal crisis. Use with caution in patients with thyroid dysfunction; changes in thyroid status may necessitate dosage adjustments; metabolic clearance of corticosteroids increases in hyperthyroid patients and decreases in hypothyroid patients. Use with caution in patients with thromboembolic tendencies or thrombophlebitis.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1051906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypothalamic-pituitary-adrenal (HPA) suppression may occur, particularly in younger children or in patients receiving high doses for prolonged periods; in infants being treated for infantile spasms, symptoms of HPA suppression may be nonspecific and include anorexia, fatigue, lethargy, weakness, excessive weight loss, hypotension, and abdominal pain. Acute adrenal insufficiency (adrenal crisis) may occur with abrupt withdrawal after long-term therapy or with stress; withdrawal and discontinuation of corticotropin should be tapered slowly and carefully; patients with HPA axis suppression may require doses of systemic glucocorticosteroids prior to, during, and after unusual stress (eg, surgery). Additionally, when used for infantile spasm, therapy should not be discontinued abruptly; withdraw gradually to lessen chance for increased seizure frequency.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Immunosuppression may occur; patients may be more susceptible to infections; prolonged use of corticotropin and corticosteroids may also increase the incidence of secondary infection, mask acute infection (including fungal infections), prolong or exacerbate viral or fungal infections, activate latent opportunistic infections, or limit response to vaccines; live or attenuated live vaccines should not be used during corticotropin therapy; exposure to chickenpox should be avoided. Close observation is required in patients with latent tuberculosis and/or TB reactivity; restrict use in active TB (only in conjunction with antituberculosis treatment).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     May cause osteoporosis (at any age) or inhibition of bone growth in pediatric patients. Use with caution in patients with osteoporosis; underlying clinical condition may also impact bone health and osteoporotic effect of corticosteroids and corticotropin (Leonard, 2006).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Corticosteroid use may cause psychiatric disturbances, including depression, euphoria, insomnia, mood swings, personality changes, and irritability (especially in infants). Antibodies may develop following prolonged use and increase the risk of hypersensitivity reactions.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F154660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors: Corticosteroids (Systemic) may enhance the adverse/toxic effect of Acetylcholinesterase Inhibitors. Increased muscular weakness may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglutethimide: May increase the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphotericin B: Corticosteroids (Systemic) may enhance the hypokalemic effect of Amphotericin B.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidiabetic Agents: Corticosteroids (Systemic) may diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): May decrease the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aprepitant: May increase the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May decrease the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcitriol: Corticosteroids (Systemic) may diminish the therapeutic effect of Calcitriol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): May decrease the metabolism of Corticosteroids (Systemic).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bepridil [Off Market].",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Corticosteroids (Systemic) may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Estrogen Derivatives: May increase the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May decrease the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosaprepitant: May increase the serum concentration of Corticosteroids (Systemic). The active metabolite aprepitant is likely responsible for this effect.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Indacaterol: May enhance the hypokalemic effect of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: Corticosteroids (Systemic) may decrease the serum concentration of Isoniazid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Corticosteroids (Systemic) may enhance the hypokalemic effect of Loop Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Corticosteroids (Systemic).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May diminish the therapeutic effect of Corticosteroids (Systemic). Mifepristone may increase the serum concentration of Corticosteroids (Systemic). Management: Avoid mifepristone in patients who require long-term corticosteroid treatment of serious illnesses or conditions (e.g., for immunosuppression following transplantation). Corticosteroid effects may be reduced by mifepristone treatment.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mitotane: May decrease the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents (Nondepolarizing): May enhance the adverse neuromuscular effect of Corticosteroids (Systemic). Increased muscle weakness, possibly progressing to polyneuropathies and myopathies, may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): Corticosteroids (Systemic) may enhance the adverse/toxic effect of NSAID (COX-2 Inhibitor).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (Nonselective): Corticosteroids (Systemic) may enhance the adverse/toxic effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Primidone: May decrease the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: May enhance the adverse/toxic effect of Corticosteroids (Systemic). Risk of tendon-related side effects, including tendonitis and rupture, may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: May increase the serum concentration of Corticosteroids (Systemic). Corticosteroids (Systemic) may decrease the serum concentration of Telaprevir. Management: Concurrent use of telaprevir and systemic corticosteroids is not recommended.  When possible, consider alternatives.  If used together, employ extra caution and monitor closely for excessive corticosteroid effects and diminished telaprevir effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Corticosteroids may decrease the serum concentration of Telaprevir. Telaprevir may increase the serum concentration of Corticosteroids.  Management: Concurrent use of telaprevir and systemic corticosteroids is not recommended.  When possible, consider alternatives.  If used together, employ extra caution and monitor closely for excessive corticosteroid effects and diminished telaprevir effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Corticosteroids (Systemic) may enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Corticosteroids (Systemic) may enhance the adverse/toxic effect of Vaccines (Live).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Warfarin: Corticosteroids (Systemic) may enhance the anticoagulant effect of Warfarin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6472588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Embryocidal effects may be observed following corticotropin use during pregnancy. Endogenous ACTH levels are increased during pregnancy. Some studies have shown an association between first trimester systemic corticosteroid use and oral clefts; adverse events in the fetus/neonate have been noted in case reports following large doses of systemic corticosteroids during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1051915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, serum glucose, potassium, and calcium and clinical presence of adverse effects. Monitor intraocular pressure (if therapy &gt;6 weeks) for signs of secondary ocular infections; linear growth of pediatric patients (with chronic use), assess HPA suppression; for infantile spasms, monitor seizure frequency, type, and duration",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1051905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stimulates the adrenal cortex to secrete adrenal steroids (including hydrocortisone, cortisone), androgenic substances, and a small amount of aldosterone. Exact mechanism of action for treatment of infantile spasms is unknown, but may be an independent antiepileptic effect (unrelated to stimulation of release of adrenocorticosteroids). One theory is that ACTH suppresses corticotropin-releasing hormone (CRH). CRH is an excitatory neuropeptide that has a greater potency in infants. Infants with infantile spasms may have increased CRH activity. ACTH may decrease CRH release and, therefore, decrease infantile spasms.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1051921\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: Cortisol serum concentration: I.M., SubQ: 3-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Repository: 10-25 hours, up to 3 days",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1051922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M.: Over 8-16 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: ACTH: 15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: In urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1051914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/48/1798?source=see_link\">",
"      see \"Corticotropin injection gel: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not abruptly discontinue the medication. Diabetic patients should monitor serum glucose closely and notify prescriber of changes as this medication can alter glycemic response. Notify prescriber of corticotropin therapy if higher than normal levels of stress are or will be experienced (eg, surgery), skin tests performed, or serious infection or injury occur. Periodic ophthalmic examinations may be necessary. Susceptibility to infection may be increased; may cause insomnia, nervousness, or irritability (especially infants). Report weakness, change in menstrual pattern, vision changes, signs of hyperglycemia, signs of infection (eg, fever, chills, mouth sores, perianal itching, vaginal discharge), or worsening of condition to the prescriber. Instruct patients to not receive live vaccines while taking this medication for long periods or in high doses.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1051924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cosyntropin is preferred over corticotropin for diagnostic test of adrenocortical insufficiency (cosyntropin is less allergenic and test is shorter in duration).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Go CY, Mackay MT, Weiss SK, et al, \"Evidence-Based Guideline Update: Medical Treatment of Infantile Spasms: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2012, 78(24):1974-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/33/14871/abstract-text/22689735/pubmed\" id=\"22689735\" target=\"_blank\">",
"        22689735",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Haines ST and Casto DT, \"Treatment of Infantile Spasms,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1994, 28(6):779-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/33/14871/abstract-text/7919570 /pubmed\" id=\"7919570 \" target=\"_blank\">",
"        7919570",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hrachovy RA and Frost JD Jr, \"Infantile Spasms,\"",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 1989, 36(2):311-29.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/33/14871/abstract-text/ 2538796 /pubmed\" id=\" 2538796 \" target=\"_blank\">",
"        2538796",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hrachovy RA, Frost JD Jr, and Glaze DG, \"High-Dose, Long-Duration Versus Low-Dose, Short-Duration Corticotropin Therapy for Infantile Spasms,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1994, 124(5 Pt 1):803-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/33/14871/abstract-text/8176573/pubmed\" id=\"8176573\" target=\"_blank\">",
"        8176573",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hrachovy RA, Frost JD Jr, Kellaway P, et al, \"Double-Blind Study of ACTH vs Prednisone Therapy in Infantile Spasms,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1983, 103(4):641-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/33/14871/abstract-text/6312008 /pubmed\" id=\"6312008 \" target=\"_blank\">",
"        6312008",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mackay MT, Weiss SK, Adams-Webber T, et al, \"Practice Parameter: Medical Treatment of Infantile Spasms: Report of the American Academy of Neurology and the Child Neurology Society,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2004, 62(10):1668-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/33/14871/abstract-text/15159460/pubmed\" id=\"15159460\" target=\"_blank\">",
"        15159460",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pellock JM, Hrachovy R, Shinnar S, et al, \"Infantile Spasms: A U.S. Consensus Report,\"",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 2010, 51(10):2175-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/33/14871/abstract-text/20608959/pubmed\" id=\"20608959\" target=\"_blank\">",
"        20608959",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13181 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-194.187.108.93-9EF4B3CCD6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14871=[""].join("\n");
var outline_f14_33_14871=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154674\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051916\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051908\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154666\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154653\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11256533\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961087\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051919\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051912\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051918\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3296141\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154692\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051923\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051907\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051906\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299095\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154660\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6472588\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051915\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051905\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051921\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051922\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051914\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1051924\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13181\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13181|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/62/2023?source=related_link\">",
"      Corticotropin injection gel: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/48/1798?source=related_link\">",
"      Corticotropin injection gel: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_33_14872="Balanitis and balanoposthitis in adults";
var content_f14_33_14872=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Balanitis and balanoposthitis in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/33/14872/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14872/contributors\">",
"     Glen W Barrisford, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/33/14872/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14872/contributors\">",
"     Michael P O'Leary, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/33/14872/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14872/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/33/14872/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balanitis is defined as inflammation of the glans penis or clitoris [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/1\">",
"     1",
"    </a>",
"    ]. The word is derived from the Greek \"balanos\" or \"acorn.\" The diagnosis is most commonly applied to male patients.",
"   </p>",
"   <p>",
"    When the prepuce (foreskin) becomes involved, the condition is then known as balanoposthitis. In common usage, \"balanitis\" and \"balanoposthitis\" are used interchangeably, although balanoposthitis occurs only in uncircumcised males. For the remainder of this discussion, we will refer to both conditions with the common term \"balanitis.\"",
"   </p>",
"   <p>",
"    The diagnosis and treatment of balanitis and balanoposthitis in adult males will be reviewed here. The disorder in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/23/24953?source=see_link\">",
"     \"Balanoposthitis in children: Clinical manifestations, diagnosis, and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33654?source=see_link\">",
"     \"Balanoposthitis in children: Epidemiology and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balanitis can occur at any age, but the prevalence of specific etiologies is age dependent. In the United States (US), balanitis accounts for approximately 11 percent of men seen in urology clinics. Approximately 3 percent of uncircumcised men are affected globally [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Balanitis appears to be more common in US men of African American and Hispanic descent, although this may relate to differences in circumcision rates among American men [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balanitis symptoms often evolve over three to seven days. The condition may present as pain, tenderness, or pruritus associated with small erythematous lesions on the glans",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the prepuce. These lesions can be ulcerated or scaly. Thick foul smelling purulent exudate is often produced (",
"    <a class=\"graphic graphic_picture graphicRef61240 \" href=\"UTD.htm?12/30/12772\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Edema may develop if symptoms are allowed to progress without treatment. The combination of inflammation and edema can result in adhesions, with adherence of the prepuce to the glans [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Persistent inflammation may result in scarring of the foreskin.",
"   </p>",
"   <p>",
"    If not properly treated, this process can evolve into a tightening of the prepuce, known as phimosis. Phimosis is an abnormal constriction of the opening in the foreskin that precludes retraction over the glans penis. The word \"phimosis\" is derived from the Greek \"phimoun,\" which means \"to muzzle.\" Severe cases of phimosis can result in erectile dysfunction or impede the urinary stream.",
"   </p>",
"   <p>",
"    Balanitis may be associated with systemic symptoms, including painful joints, dermatologic involvement beyond the penis, mouth sores, swollen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    painful glands, and malaise or fatigue. These associated findings can help elucidate the underlying etiology. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Etiology'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of balanitis or balanoposthitis is commonly based upon the physical examination, directed by a detailed history.",
"   </p>",
"   <p>",
"    Visual inspection and the verification of the absence of a paraphimosis is most important. Paraphimosis refers to the trapping of the prepuce (foreskin) behind the glans penis and is a urologic emergency (",
"    <a class=\"graphic graphic_picture graphicRef76100 \" href=\"UTD.htm?22/33/23057\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Paraphimosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The presence or absence of a prepuce may be unclear, particularly in obese men. Although most men will be able to correctly state whether or not they have been circumcised, a thorough evaluation of the penile shaft should be performed in all men to rule out a constricting band.",
"   </p>",
"   <p>",
"    The physical examination should also include inspection for urethral discharge, appearance of the penile meatus, signs of systemic infection, lymphadenopathy, arthritis, oral ulceration, and other non-genital lesions.",
"   </p>",
"   <p>",
"    Laboratory evaluation should be tailored to the clinical history and physical examination findings and may include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serum or urine glucose testing to rule out diabetes, particularly in the young patient without a prior presentation of balanitis",
"     </li>",
"     <li>",
"      Preputial swab for potassium hydroxide (KOH) microscopy",
"     </li>",
"     <li>",
"      Testing of any urethral discharge for sexually transmitted disease (chlamydia and gonorrhea)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional studies may include a wet mount slide for Gardnerella; and titers or cultures for evidence of HIV, human papillomavirus (HPV), or herpes simplex (HSV) infection in selected cases.",
"   </p>",
"   <p>",
"    Bacterial culture of the wound or discharge is generally of little value as there are a plethora of normal organisms on the glans penis, particularly when a prepuce is present.",
"   </p>",
"   <p>",
"    Referral to a urologist is appropriate whenever the diagnosis is in question or there is suspicion of an associated malignancy. Biopsy of the lesion(s) is usually indicated in cases of uncertain etiology or persistence [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following genital dermatoses may masquerade as, or coexist with, balanitis or balanoposthitis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Psoriasis may affect intertriginous areas including the inguinal, perineal, and genital regions. In particular, the form of psoriasis known as inverse psoriasis can easily be misdiagnosed as a fungal or bacterial infection since there is frequently no visible scaling. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link&amp;anchor=H12#H12\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\", section on 'Inverse psoriasis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nummular eczema consists of intensely pruritic patches of eczematous dermatitis, each showing evidence of papules, scaling, slight crusting, and some serous oozing on close inspection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H25#H25\">",
"       \"Overview of dermatitis\", section on 'Nummular dermatitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Human papillomavirus infection occurs as a single or multiple papules on the preputial cavity (glans penis, coronal sulcus, frenulum, and inner aspect of the foreskin) in uncircumcised males.",
"     </li>",
"     <li>",
"      Scabies is suggested by a small, erythematous, nondescript papule, often excoriated and tipped with blood crusts. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=see_link\">",
"       \"Scabies\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balanitis or balanoposthitis can result from a vast range of etiologies. A useful organizational scheme was presented as part of the 2001 European guideline for the management of balanoposthitis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ]. Conditions were categorized as infectious agents, skin disorders, or miscellaneous:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infectious agents",
"     </li>",
"     <li>",
"      Candidal species [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Anaerobic infection [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Aerobic infection",
"     </li>",
"     <li>",
"      Neisseria gonorrhea",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Human papillomavirus (HPV) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Herpes simplex (HSV) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Gardnerella vaginalis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Treponema pallidum (syphilis) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Trichomonal species [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Streptococci (group A and B) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/17-20\">",
"       17-20",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Borrelia vincenti (tropical ulcer, trench mouth)",
"     </li>",
"     <li>",
"      Borrelia burgdorferi (Lyme disease)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mycobacterium [Bacillus-Calmette-Guerin (BCG)] [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/21\">",
"       21",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Staphylococcus aureus",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Entamoeba histolytica [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/22\">",
"       22",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Human immunodeficiency virus (HIV) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/23\">",
"       23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Skin disorders",
"     </li>",
"     <li>",
"      Circinate balanitis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/5\">",
"       5",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Lichen",
"      <span class=\"nowrap\">",
"       sclerosis/Balanitis",
"      </span>",
"      xerotica obliterans (BXO)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Zoon's balanitis [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Erythroplasia of Queyrat (carcinoma in situ) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/5\">",
"       5",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pemphigus [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/25\">",
"       25",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pemphigoid [",
"      <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/26\">",
"       26",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Lichen planus",
"     </li>",
"     <li>",
"      Bowen's disease",
"     </li>",
"     <li>",
"      Psoriasis",
"     </li>",
"     <li>",
"      Leukoplakia",
"     </li>",
"     <li>",
"      Seborrheic dermatitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Miscellaneous",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Poor hygiene",
"     </li>",
"     <li>",
"      Trauma (zippers, inappropriate retraction)",
"     </li>",
"     <li>",
"      Irritant",
"     </li>",
"     <li>",
"      Contact",
"      <span class=\"nowrap\">",
"       dermatitis/allergy",
"      </span>",
"     </li>",
"     <li>",
"      Fixed drug eruptions",
"     </li>",
"     <li>",
"      Stevens-Johnson syndrome",
"     </li>",
"     <li>",
"      Edematous conditions (Right sided congestive heart failure, cirrhosis, nephrosis)",
"     </li>",
"     <li>",
"      Morbid obesity",
"     </li>",
"     <li>",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A number of these conditions have pathognomonic findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is of paramount importance to evaluate the patient with balanitis or balanoposthitis for a treatable etiology. Specific treatments for many of the infectious agents will eradicate or temper the condition. For conditions that are chronic (eg, herpes simplex virus and human papillomavirus), prevention of exacerbation and symptomatic management should be the goal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Candidal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida colonization of the penis can be identified in 15 to 20 percent of men and is more common in men with diabetes mellitus, who are uncircumcised, or have partners with recurrent vaginal candidiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Candida albicans is the dominant Candida species responsible.",
"   </p>",
"   <p>",
"    Symptomatic candidal infection typically presents with a painful or pruritic erythematous rash. Pruritus and burning are most noticeable after sexual intercourse.",
"   </p>",
"   <p>",
"    Examination may reveal the presence of small papules with blotchy erythema and an eroded, dry, or glazed appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ]. The diagnosis is confirmed with a sub-preputial culture or a potassium hydroxide (KOH) slide.",
"   </p>",
"   <p>",
"    Diabetes is the most common underlying medical condition associated with adult balanitis. The development of balanitis or phimosis in an otherwise healthy man can be the first presentation of undiagnosed diabetes mellitus [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/29\">",
"     29",
"    </a>",
"    ]. Poorly controlled blood glucose is associated with proliferation of Candidal species beneath the prepuce, which may lead to balanitis.",
"   </p>",
"   <p>",
"    The initial management of candidal balanitis should include evaluation for the presence of an underlying medical condition, including diabetes, HIV infection, or other causes of immunocompromise [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Local treatment includes the use of topical antifungal agents, usually for one to three weeks. First-line therapy includes a topical imidazole, either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/18/33056?source=see_link\">",
"     clotrimazole",
"    </a>",
"    (1 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/31\">",
"     31",
"    </a>",
"    ] or miconazole (2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ], applied twice daily. Alternative therapy for severe symptoms includes oral fluconazole 150 mg for one dose [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/31\">",
"     31",
"    </a>",
"    ] or 1 percent hydrocortisone cream as an adjunct to topical imidazole [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ]. Nystatin cream 100,000",
"    <span class=\"nowrap\">",
"     units/g",
"    </span>",
"    may be used if resistance or allergy to imidazoles is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ingestion of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     lactobacillus",
"    </a>",
"    containing yogurt decreases candidal colonization of the rectum and vagina among women [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. There are no studies of lactobacillus in the treatment or prevention of candidal balanitis although, on theoretical grounds, the ingestion of lactobacillus may be an adjunct to specific therapy.",
"   </p>",
"   <p>",
"    Alternate therapies are reported on internet web sites and among practitioners of herbal medicine. The primary goal appears to target candidal infections with phytogenic agents including garlic, calendula, and goldenseal. However, there are no reliable data addressing the use of any herbal agents in the treatment of balanitis.",
"   </p>",
"   <p>",
"    Circumcision has been recommended by some as a preventive therapy, although this is typically not included in standard management guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Poor hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Poor personal hygiene is a common cause for balanitis in uncircumcised men. When the prepuce is not routinely retracted, and the glans is not cleansed in an appropriate fashion, the buildup of sweat, debris, exfoliated skin, and bacterial or fungal organisms can occur. This can result in inflammation involving the sensitive genital skin.",
"   </p>",
"   <p>",
"    Retraction of the prepuce with thorough genital cleansing can be both preventive and therapeutic. Twice daily bathing of the affected area in a saline solution should be encouraged while symptoms are present [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ]. Use of soap may cause further irritation when inflammation is present&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Dermatitis/allergy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Dermatitis/allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A delicate balance must be established between overly aggressive and inadequate hygiene measures. Overuse of detergents, soaps, perfumes, condoms, and other chemicals (spermicidal agents, petroleum jelly), similar to poor hygiene, can also result in inflammation to the skin of the",
"    <span class=\"nowrap\">",
"     glans/prepuce.",
"    </span>",
"    In addition, dermatitis can result from irritation secondary to the shearing effects of clothing.",
"   </p>",
"   <p>",
"    The typical appearance of an irritative or allergic reaction can range from slight erythema to severe penile edema. The history will typically include frequent genital cleansing with soaps. If a specific agent is identified, patch testing can be conducted to determine the presence of a true allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment includes the obvious avoidance of precipitating chemicals and soaps. In the place of soaps, aqueous creams are encouraged to soften and soothe the skin surface [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/34\">",
"     34",
"    </a>",
"    ]. In addition,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    cream (1 percent) daily or twice daily can be used while symptoms are present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Anaerobic or aerobic infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaerobes (Bacteroides) have been reported as an etiology of balanitis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/8\">",
"     8",
"    </a>",
"    ]. Subpreputial anaerobic infection can result in a foul smelling discharge, inflammation and edema of the",
"    <span class=\"nowrap\">",
"     glans/prepuce,",
"    </span>",
"    erosive lesions, and inguinal lymphadenopathy.",
"   </p>",
"   <p>",
"    Anaerobic infection is typically diagnosed with subpreputial culture. Treatment regimens include oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    500 mg twice daily for seven days, oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    (375 mg three times daily for seven days), or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    topical cream (twice daily until symptoms resolve). These treatment regimens have not been evaluated in clinical trials, although they are recommended in the 2001 European guideline [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Balanitis may also result from infection with any of a number of aerobic organisms, including Streptococcus group A, Staphylococcus aureus, and Gardnerella vaginalis. Treatment is largely dependent upon the sensitivities of the organism that is isolated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Reactive arthritis (formerly Reiter syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reactive arthritis (ReA, formerly Reiter syndrome) is a multisystem disorder that primarily affects the joints, eyes, and genitourinary tract. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=see_link\">",
"     \"Reactive arthritis (formerly Reiter syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although a number of organisms can trigger the development of ReA, the most common offending agent is sexually contracted Chlamydia trachomatis. Other commonly associated infectious agents include Neisseria, Yersinia, Salmonella, Shigella, Campylobacter, or Ureaplasma. Patients with the HLA-B27 haplotype or with HIV infection, are more prone to the development of ReA.",
"   </p>",
"   <p>",
"    ReA can affect the entire genitourinary tract including the prostate, urethra, and penis. Symptoms include dysuria, prostatitis, and penile discharge as well as balanitis. The impact of ReA on the genitals is often self-limited with duration of weeks to months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Circinate balanitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Twenty to 40 percent of men with ReA develop circinate balanitis (also called balanitis circinata). Circinate balanitis can also occur without ReA.",
"   </p>",
"   <p>",
"    Circinate balanitis is characterized by small, shallow painless ulcerative lesions on the glans penis (",
"    <a class=\"graphic graphic_picture graphicRef62093 \" href=\"UTD.htm?5/9/5267\">",
"     picture 3",
"    </a>",
"    ). There may also be a serpiginous annular dermatitis that often has a grayish white granular appearance with a \"geographical\" white margin [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ]. This lesion can be mistaken for psoriasis upon physical examination, and histological evaluation cannot reliably distinguish between the two disorders. Biopsy of circinate balanitis can show pustules in the upper epidermis, similar in appearance to pustular psoriasis.",
"   </p>",
"   <p>",
"    The suggested treatment of circinate balanitis is 1 percent topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    cream daily for relief of symptoms. In addition, any concurrent infection should be treated. Systemic glucocorticoid treatment is required infrequently.",
"   </p>",
"   <p>",
"    Circinate balanitis, when it occurs as a component of ReA, is often a self-limited condition, persisting for several months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Fixed drug eruption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balanitis can represent a reaction to a number of medications. A fixed drug eruption is characterized by the recurrent appearance of a skin lesion or lesions at the same site each time the offending agent is administered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/17/41241?source=see_link\">",
"     \"Drug eruptions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most commonly offending agents are tetracyclines, salicylates, phenacetin, phenolphthalein, and some hypnotics [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6,35-37\">",
"     6,35-37",
"    </a>",
"    ]. Confirmation of the diagnosis can be performed with a repeated challenge to the offending agent.",
"   </p>",
"   <p>",
"    The pathophysiology of balanitis as a manifestation of a drug eruption is not well understood. The lesions develop over the course of 30 minutes to 8 hours. They are often notable for a round or oval plaque with erythema, edema, and sharply defined borders.",
"   </p>",
"   <p>",
"    Although this type of balanitis is often self-limited, treatment typically consists of topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    (1 percent applied twice daily), used as needed. Rarely, systemic glucocorticoids are indicated for severe disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Premalignant and potentially premalignant conditions",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Lichen sclerosus or balanitis xerotica obliterans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lichen sclerosus, a chronic inflammatory dermatosis, frequently involves the genitalia and is called genital lichen sclerosus. It is also known as balanitis xerotica obliterans (BXO) in men and is analogous to lichen sclerosus et atrophicus in women. There is a 1 percent risk of malignant transformation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36952?source=see_link\">",
"     \"Vulvar lichen planus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=see_link\">",
"     \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    BXO often presents with white penile lesions, pruritus, painful erections and voiding, and bleeding or ulceration with intercourse. There can be blisters, ulceration, or hemorrhagic vesicles. The prepuce can become thickened and phimotic.",
"   </p>",
"   <p>",
"    The diagnosis of BXO is established by biopsy. Initial findings include a thickened epidermis which, over time, becomes atrophic with follicular hyperkeratosis. In addition, loss of elastin fibers, edema, and a perivascular lymphocytic infiltrate are noted.",
"   </p>",
"   <p>",
"    The recommended treatment is daily high-potency glucocorticoids (eg, topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"     clobetasol",
"    </a>",
"    propionate 0.05% cream or ointment) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/39\">",
"     39",
"    </a>",
"    ]. Therapy is generally administered until remission and then transitioned to weekly intermittent use to maintain the remission.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"     Acitretin",
"    </a>",
"    is a systemic retinoid that is effective as alternative therapy for BXO resistant to topical glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/40\">",
"     40",
"    </a>",
"    ]. However, acitretin has several adverse effects including cheilitis, alopecia, and elevation in liver function tests.",
"   </p>",
"   <p>",
"    Circumcision is indicated in the event of phimosis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/41\">",
"     41",
"    </a>",
"    ], and meatoplasty or urethroplasty is warranted if meatal stenosis is present. Even after surgery, the skin condition still requires treatment.",
"   </p>",
"   <p>",
"    Follow-up should occur at least annually after remission has been achieved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Plasma cell (Zoon's) balanitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical appearance of plasma cell balanitis is pinpoint erythematous spots (ie, \"cayenne pepper spots\") [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ]. This condition may appear similar to erythroplasia of Queyrat, which is carcinoma in situ of the penis. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Carcinoma in situ'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Biopsy to rule out a premalignant condition is recommended. The appearance on biopsy is consistent with epidermal atrophy, loss of rete ridges,",
"    <span class=\"nowrap\">",
"     keratinocytes/spongiosis,",
"    </span>",
"    and a subepidermal plasma cell infiltrate.",
"   </p>",
"   <p>",
"    Treatment regimens include circumcision, topical glucocorticoids, or carbon dioxide laser [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The lesions may resolve with circumcision [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/42\">",
"     42",
"    </a>",
"    ]. Topical glucocorticoid preparations or combination glucocorticoid and antibiotic creams are often recommended, although there is no evidence of effectiveness [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Carcinoma in situ",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carcinoma in situ (CIS) of the glans penis is known as erythroplasia of Queyrat. The typical appearance is a well-circumscribed red velvety lesion. Induration and white patches are often indicative of the presence of squamous cell carcinoma. Biopsy is imperative to determine the diagnosis. When CIS is associated with human papilloma virus (HPV), it is known as Bowenoid papulosis. CIS can develop into frank squamous cell carcinoma, known as Bowen's disease.",
"   </p>",
"   <p>",
"    The diagnosis and treatment of these conditions is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=see_link\">",
"     \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/21/42328?source=see_link\">",
"     \"Carcinoma of the penis: Clinical presentation and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balanitis is not associated with increased mortality. Morbidity includes the development of pain, ulcerative lesions of the",
"    <span class=\"nowrap\">",
"     glans/prepuce,",
"    </span>",
"    phimosis, paraphimosis,",
"    <span class=\"nowrap\">",
"     meatal/urethral",
"    </span>",
"    stricture, and malignant transformation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Phimosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phimosis, an abnormal constriction of the opening in the foreskin that precludes retraction over the glans penis, results from chronic inflammation and edema of the prepuce. Although development of a phimosis often complicates sexual function, voiding, and hygiene, it is generally not considered an emergent condition. However, if the individual (or medical staff) forcibly retracts the prepuce, a paraphimosis can occur.",
"   </p>",
"   <p>",
"    Phimosis can be treated in the emergent setting by dilation using a surgical clamp and pain medication. In the event this is not successful, a dorsal slit circumcision can be performed by a urologist to temporize the problem. Definitive treatment, under elective circumstances, is complete circumcision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Paraphimosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paraphimosis refers to the trapping of the prepuce (foreskin) behind the glans penis, and is a urologic emergency (",
"    <a class=\"graphic graphic_picture graphicRef76100 \" href=\"UTD.htm?22/33/23057\">",
"     picture 2",
"    </a>",
"    ). The constricting foreskin has become located proximal to the glans penis. Under these circumstances, the constricting band will limit the venous and lymphatic outflow while allowing continued arterial inflow. Over the course of minutes to hours the glans will increase in size and become exquisitely painful. This must be addressed by a urologist or a clinician familiar with reduction of a paraphimosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33543?source=see_link\">",
"     \"Paraphimosis reduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The single most important step in treatment is making the correct diagnosis. In the hospital setting, the diagnosis can often be complicated by abnormal mental status or sedation of the patient. Medical staff may identify a \"red penis\" and assume that the diagnosis is balanitis alone. However, closer inspection can reveal the constricting prepuce.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/12/14530?source=see_link\">",
"       \"Patient information: Lichen sclerosus (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/29/40401?source=see_link\">",
"       \"Patient information: Balanitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Balanitis is inflammation of the glans penis, and balanoposthitis includes inflammation of the prepuce or foreskin; both conditions are referred to subsequently with the common term \"balanitis.\" (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Balanitis may present as pain, tenderness, or pruritus associated with small erythematous lesions on the glans",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the prepuce; an exudate may also be present. Balanitis may be associated with other symptoms involving joints, mouth sores, or generalized systemic symptoms. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physical examination should include careful inspection for possible paraphimosis (trapping of the prepuce behind the glans penis), as well as evaluation of the genitals, oral mucosa, joints, and skin. Laboratory testing may include serum or urine glucose, gram stain and culture of discharge, swab for KOH microscopy, and testing for sexually transmitted disease. Biopsy of lesions should be considered in cases of uncertain etiology or persistence. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common cause of balanitis is poor personal hygiene in uncircumcised males. However, over aggressive hygiene measures with soaps can also trigger an inflammatory reaction. We suggest twice daily bathing of the affected area in saline and avoidance of chemical irritants (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We also suggest topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      (1 percent) applied once or twice daily when symptoms are present (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Poor hygiene'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Candidal balanitis may be a presenting symptom of diabetes mellitus, and patients should be evaluated for diabetes. We suggest initial treatment with a topical imidazole (either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/18/33056?source=see_link\">",
"       clotrimazole",
"      </a>",
"      1 percent or miconazole 2 percent) applied twice daily (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"       fluconazole",
"      </a>",
"      is equally effective but more costly. Topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/53/32592?source=see_link\">",
"       nystatin",
"      </a>",
"      is an alternative for patients allergic to imidazoles. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Candidal infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Circinate balanitis may occur associated with reactive arthritis (formerly known as Reiters) or as an isolated condition. Balanitis may also be seen as a manifestation of a fixed drug eruption. Either condition may respond to topical 1 percent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Circinate balanitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Fixed drug eruption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lichen sclerosus involving the male genitalia is known as balanitis xerotica obliterans (BXO). This condition, diagnosed by biopsy, has a 1 percent risk of malignant transformation and regular annual follow-up is suggested once remission has been achieved by treatment with high-potency topical steroids. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Lichen sclerosus or balanitis xerotica obliterans'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Phimosis, a constriction of the opening of the prepuce so that it cannot be retracted over the glans penis, is a possible complication of balanitis. Paraphimosis is the trapping of the prepuce behind the glans penis and requires urgent reduction. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     The American Heritage Stedman's Medical Dictionary. Available at: file://dictionary.reference.com/browse/balanitis (Accessed on April 04, 2008).",
"    </li>",
"    <li>",
"     Leber M. Balanitis. Available at: www.emedicine.com/emerg/topic51.htm (Accessed on April 04, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/3\">",
"      Edwards S. Balanitis and balanoposthitis: a review. Genitourin Med 1996; 72:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/4\">",
"      Palamaras I, Hamill M, Sethi G, et al. The usefulness of a diagnostic biopsy clinic in a genitourinary medicine setting: recent experience and a review of the literature. J Eur Acad Dermatol Venereol 2006; 20:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/5\">",
"      Buechner SA. Common skin disorders of the penis. BJU Int 2002; 90:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/6\">",
"      Edwards SK, European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization. European guideline for the management of balanoposthitis. Int J STD AIDS 2001; 12 Suppl 3:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/7\">",
"      Mayser P, Sch&uuml;tz M, Schuppe HC, et al. Frequency and spectrum of Malassezia yeasts in the area of the prepuce and glans penis. BJU Int 2001; 88:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/8\">",
"      Cree GE, Willis AT, Phillips KD, Brazier JS. Anaerobic balanoposthitis. Br Med J (Clin Res Ed) 1982; 284:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/9\">",
"      Wikstr&ouml;m A, von Krogh G, Hedblad MA, Syrj&auml;nen S. Papillomavirus-associated balanoposthitis. Genitourin Med 1994; 70:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/10\">",
"      Birley HD, Luzzi GA, Walker MM, et al. The association of human papillomavirus infection with balanoposthitis: a description of five cases with proposals for treatment. Int J STD AIDS 1994; 5:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/11\">",
"      Peutherer JF, Smith IW, Robertson DH. Necrotising balanitis due to a generalised primary infection with herpes simplex virus type 2. Br J Vener Dis 1979; 55:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/12\">",
"      Kinghorn GR, Jones BM, Chowdhury FH, Geary I. Balanoposthitis associated with Gardnerella vaginalis infection in men. Br J Vener Dis 1982; 58:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/13\">",
"      Burdge DR, Bowie WR, Chow AW. Gardnerella vaginalis-associated balanoposthitis. Sex Transm Dis 1986; 13:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/14\">",
"      Babu CS, Vitharana S, Higgins SP. Primary syphilis presenting as balanitis. Int J STD AIDS 2007; 18:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/15\">",
"      Kishimoto M, Lee MJ, Mor A, et al. Syphilis mimicking Reiter's syndrome in an HIV-positive patient. Am J Med Sci 2006; 332:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/16\">",
"      Michalowski R. [Trichomonal balano-posthitis. Report of 16 cases (author's transl)]. Ann Dermatol Venereol 1981; 108:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/17\">",
"      Orden B, Manjavacas CG, Martinez R, Franco A. Streptococcal balanitis in a healthy adult male. Eur J Clin Microbiol Infect Dis 1995; 14:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/18\">",
"      Kyriazi NC, Costenbader CL. Group A beta-hemolytic streptococcal balanitis: it may be more common than you think. Pediatrics 1991; 88:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/19\">",
"      Lucks DA, Venezio FR, Lakin CM. Balanitis caused by group B streptococcus. J Urol 1986; 135:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/20\">",
"      Cruz-Rojo J, Mart&iacute;nez Garc&iacute;a MM, Fern&aacute;ndez L&oacute;pez MC. [Group A beta-hemolytic Streptococcus as a cause of perianal dermatitis, fissures and balanoposthitis]. An Pediatr (Barc) 2005; 62:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/21\">",
"      Yusuke H, Yoshinori H, Kenichi M, Akio H. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy. Int J Urol 2006; 13:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/22\">",
"      Rodrigue RB. Amebic balanitis. JAMA 1978; 239:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/23\">",
"      Davis P, Stein M. Human immunodeficiency virus-related connective tissue diseases: a Zimbabwean perspective. Rheum Dis Clin North Am 1991; 17:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/24\">",
"      ZOON JJ. [Differential diagnosis between chronic circumscribed benign plasmacellular balanitis and Queyrat's erythroplasia]. Ned Tijdschr Geneeskd 1952; 96:2349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/25\">",
"      Castle WN, Wentzell JM, Schwartz BK, et al. Chronic balanitis owing to pemphigus vegetans. J Urol 1987; 137:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/26\">",
"      Kirtschig G, Mengel R, Mittag H, et al. Desquamative gingivitis and balanitis--linear IgA disease or cicatricial pemphigoid? Clin Exp Dermatol 1998; 23:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/27\">",
"      David LM, Walzman M, Rajamanoharan S. Genital colonisation and infection with candida in heterosexual and homosexual males. Genitourin Med 1997; 73:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/28\">",
"      Mayser P. Mycotic infections of the penis. Andrologia 1999; 31 Suppl 1:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/29\">",
"      Hershfield M, Dahlen CP. Phimosis with balanoposthitis in previously undiagnosed diabetes mellitus. GP 1968; 38:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/30\">",
"      Rodriguez A, Hill B, Gopolan R, Sklar GN. Cytomegalovirus balanitis in a renal transplant recipient. J Urol 1999; 162:2086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/31\">",
"      Stary A, Soeltz-Szoets J, Ziegler C, et al. Comparison of the efficacy and safety of oral fluconazole and topical clotrimazole in patients with candida balanitis. Genitourin Med 1996; 72:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/32\">",
"      Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992; 116:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/33\">",
"      Shalev E, Battino S, Weiner E, et al. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996; 5:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/34\">",
"      Birley HD, Walker MM, Luzzi GA, et al. Clinical features and management of recurrent balanitis; association with atopy and genital washing. Genitourin Med 1993; 69:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/35\">",
"      S&aacute;nchez-P&eacute;rez J, C&oacute;rdoba S, Cortizas CF, Garc&iacute;a-D&iacute;ez A. Allergic contact balanitis due to tetracaine (amethocaine) hydrochloride. Contact Dermatitis 1998; 39:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/36\">",
"      Dodds PR, Chi TN. Balanitis as a fixed drug eruption to tetracycline. J Urol 1985; 133:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/37\">",
"      Csonka GW, Rosedale N, Walkden L. Balanitis due to fixed drug eruption associated with tetracycline therapy. Br J Vener Dis 1971; 47:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/38\">",
"      Bernstein G, Forgaard DM, Miller JE. Carcinoma in situ of the glans penis and distal urethra. J Dermatol Surg Oncol 1986; 12:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/39\">",
"      Dahlman-Ghozlan K, Hedblad MA, von Krogh G. Penile lichen sclerosus et atrophicus treated with clobetasol dipropionate 0.05% cream: a retrospective clinical and histopathological study. J Am Acad Dermatol 1999; 40:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/40\">",
"      Ioannides D, Lazaridou E, Apalla Z, et al. Acitretin for severe lichen sclerosus of male genitalia: a randomized, placebo controlled study. J Urol 2010; 183:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/41\">",
"      Liatsikos EN, Perimenis P, Dandinis K, et al. Lichen sclerosus et atrophicus. Findings after complete circumcision. Scand J Urol Nephrol 1997; 31:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/42\">",
"      Kumar B, Sharma R, Rajagopalan M, Radotra BD. Plasma cell balanitis: clinical and histopathological features--response to circumcision. Genitourin Med 1995; 71:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14872/abstract/43\">",
"      Boon TA. Sapphire probe laser surgery for localized carcinoma of the penis. Eur J Surg Oncol 1988; 14:193.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6876 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-78.134.254.52-42756325B5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14872=[""].join("\n");
var outline_f14_33_14872=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Candidal infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Poor hygiene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Dermatitis/allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Anaerobic or aerobic infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Circinate balanitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Fixed drug eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Premalignant and potentially premalignant conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Lichen sclerosus or balanitis xerotica obliterans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Plasma cell (Zoon's) balanitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Carcinoma in situ",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Phimosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Paraphimosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6876\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6876|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/30/12772\" title=\"picture 1\">",
"      Group A streptococcal balanoposthitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/33/23057\" title=\"picture 2\">",
"      Paraphimosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/9/5267\" title=\"picture 3\">",
"      Circinate balanitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/23/24953?source=related_link\">",
"      Balanoposthitis in children: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33654?source=related_link\">",
"      Balanoposthitis in children: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/21/42328?source=related_link\">",
"      Carcinoma of the penis: Clinical presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=related_link\">",
"      Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/17/41241?source=related_link\">",
"      Drug eruptions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=related_link\">",
"      Overview of dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33543?source=related_link\">",
"      Paraphimosis reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/29/40401?source=related_link\">",
"      Patient information: Balanitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/12/14530?source=related_link\">",
"      Patient information: Lichen sclerosus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=related_link\">",
"      Scabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36952?source=related_link\">",
"      Vulvar lichen planus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_33_14873="Advanced case 8 with answer";
var content_f14_33_14873=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63096&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63096&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Hyperkalemia in renal failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram showing peaked T waves (most apparent in V2 to V5) characteristic of hyperkalemia. The concurrent evidence of hypocalcemia (prolonged QTc interval of 0.40 sec) and chronic hypertension (left atrial abnormality, as shown by biphasic P wave in lead V1, and voltage criteria for left ventricular hypertrophy) suggests that the hyperkalemia is due to renal failure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14873=[""].join("\n");
var outline_f14_33_14873=null;
var title_f14_33_14874="Classification of diabetes mellitus and genetic diabetic syndromes";
var content_f14_33_14874=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Classification of diabetes mellitus and genetic diabetic syndromes",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/33/14874/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14874/contributors\">",
"     David K McCulloch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/33/14874/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14874/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14874/contributors\">",
"     Joseph I Wolfsdorf, MB, BCh",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/33/14874/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/33/14874/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/33/14874/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type 2 diabetes accounts for over 90 percent of cases of diabetes in the United States, Canada, and Europe; type 1 diabetes accounts for another 5 to 10 percent, with the remainder due to other causes (",
"    <a class=\"graphic graphic_table graphicRef59403 \" href=\"UTD.htm?41/22/42349\">",
"     table 1",
"    </a>",
"    ). New information has led to increased understanding of genetic defects related to diabetes. Monogenic causes of type 2 diabetes (eg, those causing maturity onset diabetes of the young) represent only a small fraction of cases, and commonly inherited polymorphisms individually contribute only small degrees of risk for, or protection from, diabetes. Most of the genetic risk for type 2 diabetes results from complex polygenic risk factors.",
"   </p>",
"   <p>",
"    The etiologic classification of diabetes mellitus will be reviewed here. The definition and diagnostic criteria for diabetes mellitus are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38758?source=see_link\">",
"     \"Diagnosis of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TYPE 1 DIABETES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type 1 diabetes is characterized by destruction of the pancreatic beta cells, leading to absolute insulin deficiency. This is usually due to autoimmune destruction of the beta cells (type 1A). Testing for islet cell antibodies (ICA) or other islet autoantibodies (antibodies to glutamic acid decarboxylase [GAD65], insulin, and to the tyrosine phosphatases, IA-2 and IA-2&beta;, and zinc transporter ZnT8) in serum may be helpful if establishing the diagnosis is important; a positive result is indicative of immune-mediated or type 1A diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/1\">",
"     1",
"    </a>",
"    ]. However, some patients with absolute insulin deficiency have no evidence of autoimmunity and have no other known cause for beta-cell destruction. They are said to have idiopathic or type 1B diabetes mellitus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link\">",
"     \"Pathogenesis of type 1 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The current American Diabetes Association (ADA) classification of diabetes mellitus does not reflect the clinical heterogeneity of patients with diabetes and the emergence of the concept that early beta cell dysfunction is likely to be a primary defect in the pathophysiology of diabetes, regardless of \"type.\" Other classification schemes have been proposed, accounting for beta cell autoimmunity, beta cell function, clinical features, and body weight. The high prevalence of",
"    <span class=\"nowrap\">",
"     overweight/obesity",
"    </span>",
"    in the population has further complicated classification systems with an added element of insulin resistance even in type 1 diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32920?source=see_link&amp;anchor=H23#H23\">",
"     \"Syndromes of ketosis-prone diabetes mellitus\", section on 'Classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is anticipated that other subtypes of type 1 (and type 2 diabetes) will become more clearly defined in the future.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H247196672\">",
"    <span class=\"h2\">",
"     Latent autoimmune diabetes in adults (LADA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older studies in predominantly Scandinavian populations have suggested that as many as 7.5 to 10 percent of adults in populations with a high prevalence of type 1 diabetes and with apparent type 2 diabetes may have circulating autoantibodies directed against pancreatic beta-cell antigens (islet-cell antibodies [ICA] or glutamic acid decarboxylase [GAD65]) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The prevalence of LADA is almost certainly lower in the more diverse US population. These adults do not require insulin at diagnosis but progress to insulin dependence after several months to years. This entity is sometimes referred to as \"latent autoimmune diabetes in adults\" (LADA) and may account for a very small fraction of all cases of diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/5-7\">",
"     5-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In genotyping analyses, LADA shares genetic features of both type 1 and type 2 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. As an example, in one analysis, patients with LADA shared an increased frequency of risk for an HLA-DQB1 genotype with patients with type 1 diabetes and for a variant in the transcription factor 7-like 2 (TCF7L2) gene with patients with type 2 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/8\">",
"     8",
"    </a>",
"    ]. The variant in TCF7L2 has been shown to increase the risk for type 2 diabetes in several populations, and the effect size was similar for LADA and type 2 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/9\">",
"     9",
"    </a>",
"    ]. Thus, LADA appears to be on the spectrum of insulin deficiency between type 1 and type 2 diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link&amp;anchor=H5#H5\">",
"     \"Pathogenesis of type 1 diabetes mellitus\", section on 'Autoimmunity'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=see_link&amp;anchor=H8#H8\">",
"     \"Pathogenesis of type 2 diabetes mellitus\", section on 'Genetic susceptibility'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with LADA are a heterogeneous group of patients with variable titers of antibodies, body mass index, and frequency of progression to insulin independence [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients with high compared with low titers of GAD65 antibodies usually have a lower body mass index, less endogenous insulin secretion (as measured by stimulated serum C-peptide concentrations), and progress more quickly to insulin dependence [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Thus, the presence and titers of anti-GAD antibodies (or ICA) can help to identify patients thought to have type 2 diabetes, who are likely to respond poorly to oral hypoglycemic drug therapy, require insulin, and to be at increased risk for developing ketoacidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/4,5,11-13\">",
"     4,5,11-13",
"    </a>",
"    ]. Studies are underway to determine whether early treatment with insulin or use of immunomodulator therapy can prevent disease progression [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Distinguishing type 1 from type 2 diabetes'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TYPE 2 DIABETES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type 2 diabetes is by far the most common type of diabetes in adults and is characterized by hyperglycemia and variable degrees of insulin deficiency and resistance. It is a common disorder whose prevalence rises markedly with increasing degrees of obesity. Insulin resistance and insulin deficiency can arise through genetic or environmental influences, making it difficult to determine the exact cause in an individual patient. In addition, hyperglycemia itself can impair pancreatic beta cell function and exacerbate insulin resistance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=see_link\">",
"     \"Pathogenesis of type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H270106199\">",
"    <span class=\"h2\">",
"     DKA in type 2 diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with type 2 diabetes typically present with hyperglycemia, although ketoacidosis can occur. Diabetic ketoacidosis in type 2 diabetes occurs by several mechanisms, similar to those in type 1 diabetes. The stress of infection or other illness causes increased secretion of counterregulatory hormones and further increases insulin resistance. The already impaired insulin secretion is unable to respond to the increased demand, leading to hyperglycemia, which may further impair insulin secretion via glucose toxicity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32920?source=see_link\">",
"     \"Syndromes of ketosis-prone diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DISTINGUISHING TYPE 1 FROM TYPE 2 DIABETES",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is occasionally difficult to distinguish between type 1 and atypical presentations of type 2 diabetes. Patients with type 1 diabetes have an absolute requirement for insulin therapy. However, many patients with type 2 diabetes lose beta cell function over time and require insulin for glucose control. Thus, need for insulin per se does not distinguish between type 1 and type 2 diabetes. While it is known that diabetic ketoacidosis (DKA) can occur in the presence of complete insulin deficiency, and it is not a typical feature of type 2 diabetes, some patients with type 2 diabetes develop diabetic ketoacidosis under certain circumstances (usually severe infection or other illness). Thus, ketoacidosis cannot be relied upon as an absolute indicator that the patient has type 1 diabetes or that long-term insulin therapy will be required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32920?source=see_link\">",
"     \"Syndromes of ketosis-prone diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, patients with type 1 diabetes may coincidentally have pathophysiologic elements of type 2 diabetes. In the past, poor metabolic control of type 1 diabetes prevented most of these patients from gaining weight. Intensive therapy now commonly used to manage type 1 diabetes has resulted in approximately 20 to 30 percent of type 1 diabetic patients becoming overweight or obese. Insulin resistance and other features of type 2 diabetes may be exhibited in overweight patients with type 1 diabetes, especially those who also have a family history of type 2 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of GAD and islet cell antibodies in patients with presumed type 2 diabetes can identify patients who actually have type 1 diabetes (LADA) who are more likely to require insulin [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/4,5,12,13\">",
"     4,5,12,13",
"    </a>",
"    ]. Based upon a review of clinical features in 102 adult diabetic patients who did not initially require insulin but who were positive for anti-GAD antibodies, a screening tool was developed to identify adult patients with newly diagnosed diabetes who should be considered for antibody testing [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/15\">",
"     15",
"    </a>",
"    ]. These features are: age of onset &lt;50 years, acute symptoms, BMI &lt;25",
"    <span class=\"nowrap\">",
"     kg/m2,",
"    </span>",
"    and personal or family history of autoimmune disease. The presence of two or more criteria had a 90 percent sensitivity and 71 percent specificity for identifying patients positive for anti-GAD antibodies.",
"   </p>",
"   <p>",
"    We often measure autoantibodies (GAD65, insulin, tyrosine phosphatases [IA-2 and IA-2&beta;], islet cell) when the diagnosis of type 1 or type 2 diabetes is uncertain by clinical presentation (ie, thin patient with poor response to initial therapy with sulfonylureas or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    , personal or family history of autoimmune disease). If one or more of the antibodies is present, and especially if two or more are positive, the patient should be presumed to have type 1 diabetes and should be treated with insulin replacement therapy, as these patients respond poorly to diet and oral hypoglycemic drug therapy.",
"   </p>",
"   <p>",
"    Given the risk of ketoacidosis, insulin should also be started in any patient, regardless of whether they are thought to have type 1 or type 2 diabetes, who is catabolic (weight loss or dehydration in the setting of hyperglycemia) or who has evidence of increased ketogenesis (ketonuria or acidosis). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/20/24906?source=see_link\">",
"     \"Insulin therapy in adults with type 1 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/24/30089?source=see_link&amp;anchor=H22#H22\">",
"     \"Insulin therapy in type 2 diabetes mellitus\", section on 'Insulin as initial therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     GENETIC DEFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the human genome is further explored, it is likely that multiple genetic anomalies at different loci will be found that confer varying degrees of predisposition to type 1 and type 2 diabetes. Polymorphisms of multiple genes are reported to influence the risk of type 1A diabetes, including genes in both the major histocompatibility complex (MHC) and elsewhere in the genome, but only HLA alleles have a large effect, followed by insulin gene polymorphisms, and PTPNN22. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis of type 1 diabetes mellitus\", section on 'Genetic susceptibility'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Numerous common polymorphisms (approximately 50 to date) weakly contribute to the risk for or protection from type 2 diabetes. The genes encode proteins that cause alterations in several pathways leading to diabetes, including pancreatic development, insulin synthesis, processing, and secretion; amyloid deposition in beta cells; cellular insulin resistance; and impaired regulation of gluconeogenesis. Monogenic causes of type 2 diabetes represent only a small fraction of cases and commonly inherited polymorphisms individually contribute only small degrees of risk for, or protection from, diabetes. Most of the genetic risk for type 2 diabetes results from complex polygenic risk factors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=see_link&amp;anchor=H8#H8\">",
"     \"Pathogenesis of type 2 diabetes mellitus\", section on 'Genetic susceptibility'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Maturity onset diabetes of the young",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maturity onset diabetes of the young (MODY) is a clinically heterogeneous disorder characterized by non-insulin dependent diabetes diagnosed at a young age (&lt;25 years) with autosomal dominant transmission and lack of autoantibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/16\">",
"     16",
"    </a>",
"    ]. MODY is the most common form of monogenic diabetes, accounting for 2 to 5 percent of diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The population prevalence of MODY in the UK is estimated to be 68 to 108 cases per million [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/19\">",
"     19",
"    </a>",
"    ]. These patients are quite heterogeneous and clinical characteristics may not be reliable in predicting the underlying pathogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Many patients are misclassified as having either type 1 or 2 diabetes.",
"   </p>",
"   <p>",
"    Several different genetic abnormalities have been identified, each leading to a different type of disease. The subtypes of MODY are defined by specific descriptions of the known genetic defects (",
"    <a class=\"graphic graphic_table graphicRef83071 \" href=\"UTD.htm?36/32/37388\">",
"     table 2",
"    </a>",
"    ). The genes involved control pancreatic beta cell development, function, and regulation, and the mutations in these genes cause impaired glucose sensing and insulin secretion with minimal or no defect in insulin action [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/22\">",
"     22",
"    </a>",
"    ]. Mutations in hepatocyte nuclear factor-1-alpha (HNF1A) and the glucokinase (GCK) gene are most commonly identified, occurring in 52 to 65 and 15 to 32 percent of MODY cases, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/21,23\">",
"     21,23",
"    </a>",
"    ]. Mutations in HNF4A account for approximately 10 percent of cases. Some members of a family have the genetic defect but do not develop diabetes; the reason for this is unclear. Other patients may have the classic MODY phenotype but do not have an identifiable mutation in any of the MODY genes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Hepatocyte nuclear factor-4-alpha",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the hepatocyte nuclear factor-4-alpha (HNF4A) gene on chromosome 20 cause the condition formerly called MODY1 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/24\">",
"     24",
"    </a>",
"    ]. HNF4A is expressed both in the liver and in pancreatic beta cells. One of its functions is to regulate positively the activity of HNF1A, the affected gene in the previously labeled MODY3 syndrome. The precise mechanism by which a defect in HNF4A causes hyperglycemia is not clear, but it has been associated with a reduced insulin secretory response to glucose, suggesting a primary genetic defect in insulin secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. The secretory defect is progressive and patients typically present with hyperglycemia in adolescence or early childhood. Although the initial response to sulfonylureas is good, patients may require insulin as the secretory defect progresses. These patients are at risk for the microvascular and macrovascular complications of type 1 and type 2 diabetes mellitus.",
"   </p>",
"   <p>",
"    Although HNF4A plays a central role in the hepatic synthesis of lipoprotein and coagulation proteins, these functions are largely maintained in HNF4A diabetes, suggesting that this disorder is primarily one of impaired pancreatic beta-cell function [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Glucokinase gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than a dozen mutations in the glucokinase gene on chromosome 7 have been described, and were formerly called MODY2 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/28\">",
"     28",
"    </a>",
"    ]. Defects in the expression of glucokinase, which phosphorylates glucose to glucose-6-phosphate and probably acts as a glucose sensor, result in a higher threshold for glucose stimulated insulin secretion. On occasion, the expressed enzyme functions but is unstable, again leading to an insulin secretory deficit [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41702?source=see_link\">",
"     \"Insulin secretion and pancreatic beta-cell function\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The resulting hyperglycemia is often stable, mild, and is not associated with the vascular complications that are so common in other types of diabetes mellitus [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/30\">",
"     30",
"    </a>",
"    ]. Patients with mutation in the glucokinase gene can often be controlled with diet alone. Markers in the glucokinase locus have been linked to non-monogenic type 2 diabetes in American blacks [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/31\">",
"     31",
"    </a>",
"    ] and some other ethnic groups, but not in whites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Hepatocyte nuclear factor-1-alpha",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of several mutations in the hepatocyte nuclear factor-1-alpha (HNF1A) gene on chromosome 12 was formerly called MODY3 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/32\">",
"     32",
"    </a>",
"    ]. This form of diabetes is more common among European patients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. HNF1A is a weak transactivator of the insulin gene in beta cells. Mutations of HNF1A can lead to abnormal insulin secretion; whether this or some other action is defective enough to cause diabetes mellitus is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/34\">",
"     34",
"    </a>",
"    ]. Mutations also result in a low renal threshold for glucose. Thus, prior to onset of diabetes, mutation carriers have detectable glycosuria provoked by glucose loading [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/35\">",
"     35",
"    </a>",
"    ]. Testing for glycosuria two hours after a glucose load could be used to screen children of mutation carriers and guide the need for further evaluation.",
"   </p>",
"   <p>",
"    Patients with HNF1A diabetes have a similar clinical phenotype as patients with HNF4A diabetes. Patients exhibit increased insulin sensitivity and marked sensitivity to the hypoglycemic effects of sulfonylureas compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    (fall in FPG 85 versus 16",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.7 versus 0.9",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    and compared with patients with type 2 diabetes (3.9-fold greater reduction in FPG) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/36\">",
"     36",
"    </a>",
"    ]. Thus, patients with mutations in the HNF1a gene can be successfully treated with sulfonylurea monotherapy, and in one clinical study, approximately 70 percent of patients previously treated with insulin successfully switched to sulfonylureas once an HNF1A mutation was identified [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/37\">",
"     37",
"    </a>",
"    ]. These patients are at risk for microvascular and macrovascular complications of type 1 and type 2 diabetes mellitus. In addition, patients with diabetes caused by a mutation in HNF1A appear to have an increased risk of cardiovascular mortality compared with unaffected family members [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Insulin promoter factor 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the insulin promoter factor 1 (IPF1) gene can lead to what was called MODY4 by reduced binding of the protein to the insulin gene promoter [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/39,40\">",
"     39,40",
"    </a>",
"    ] and perhaps by altering fibroblast growth factor signaling in beta cells [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/41\">",
"     41",
"    </a>",
"    ]. Less severe mutations in IPF1 may predispose to late onset type 2 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/40,42\">",
"     40,42",
"    </a>",
"    ]. In addition, nondiabetic carriers have higher blood glucose concentrations and lower insulin-to-glucose ratios than nondiabetic family members without a mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Hepatocyte nuclear factor-1-beta",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the HNF1B gene produce a syndrome that was formerly called MODY5 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/44-47\">",
"     44-47",
"    </a>",
"    ]. Affected patients can develop a variety of manifestations in addition to early onset diabetes. These include pancreatic atrophy (on CT scan), abnormal renal development (renal dysplasia that can be detected on ultrasonography in the fetus, single or multiple renal cysts, glomerulocystic disease, oligomeganephronia [a form of renal hypoplasia]), slowly progressive renal insufficiency, hypomagnesemia, elevated serum aminotransferases, and genital abnormalities (epididymal cysts, atresia of vas deferens, and bicornuate uterus) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10935?source=see_link&amp;anchor=H2#H2\">",
"     \"Renal hypoplasia\", section on 'Overview'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/41/2712?source=see_link&amp;anchor=H7#H7\">",
"     \"Renal cystic diseases in children\", section on 'Glomerular cortical cysts'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/41/15000?source=see_link&amp;anchor=H8658144#H8658144\">",
"     \"Causes of hypomagnesemia\", section on 'Hepatocyte nuclear factor-1-beta gene mutations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/41/15000?source=see_link\">",
"     \"Causes of hypomagnesemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, some patients have a phenotype consistent with familial juvenile hyperuricemic nephropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=see_link&amp;anchor=H6#H6\">",
"     \"Uric acid renal diseases\", section on 'Familial juvenile hyperuricemic nephropathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One of the functions of HNF1B is the regulation of tissue-specific gene expression. In the kidney, the proximal promoter of the Pkhd1 gene has a binding site for HNF1B. Mutations in HNF1B inhibit the expression of Pkhd1 and lead to cyst formation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/47\">",
"     47",
"    </a>",
"    ]. This is not surprising since mutations in Pkhd1 are responsible for the autosomal recessive form of polycystic kidney disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29913?source=see_link&amp;anchor=H88678691#H88678691\">",
"     \"Autosomal recessive polycystic kidney disease in children\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Neurogenic differentiation factor-1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the gene for neurogenic differentiation factor-1 (also called NEUROD1 or BETA2) can lead to what was called MODY6 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. NEUROD1 normally functions as a regulatory switch for endocrine pancreatic development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3753980\">",
"    <span class=\"h3\">",
"     Other genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in carboxyl ester lipase (CEL); insulin (INS); ATP-binding cassette, subfamily C, member 8 (ABCC8); potassium channel, inwardly rectifying, subfamily J, member 11 (KCNJ11); and paternal uniparental isodisomy of chromosome 6q24 (UPD6) genes have also been associated with the MODY phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/22\">",
"     22",
"    </a>",
"    ]. Mutations in INS, ABCC8, and KCNJ11 are more commonly associated with neonatal diabetes mellitus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37816?source=see_link&amp;anchor=H12#H12\">",
"     \"Neonatal hyperglycemia\", section on 'Neonatal diabetes mellitus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3754064\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of MODY is made by performing diagnostic genetic testing by direct sequencing of the gene. Laboratories in several countries offer clinical testing, primarily for mutations in HNF4A, HNF1A, and the glucokinase gene. A list of laboratories is available on the",
"    <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/sites/GeneTests/lab?db=GeneTests\">",
"     GeneTests website",
"    </a>",
"    . Only CLIA (Clinical laboratory Improvement Amendments) certified labs should be used. Genetic testing should only be performed after informed consent and genetic counseling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=see_link&amp;anchor=H27#H27\">",
"     \"Genetic counseling and testing\", section on 'Genetic testing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4885959\">",
"    <span class=\"h3\">",
"     Indications for genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to distinguish MODY from type 1 and type 2 diabetes because the optimal treatment and risk for diabetes complications varies with the underlying genetic defect. As an example, patients with MODY due to HNF1A or HNF4A mutations are frequently misdiagnosed as having insulin requiring type 1 diabetes because they present at an early age and are not obese. However, many of these patients can be successfully managed with sulfonylureas monotherapy. In addition, distinguishing MODY from type 1 and type 2 diabetes allows earlier identification of at risk family members.",
"   </p>",
"   <p>",
"    We typically perform genetic testing for MODY when there is a high index of suspicion (familial diabetes with autosomal dominant pattern of inheritance (&gt;2 generations), onset &lt;25 years, non-obese, negative islet autoantibodies) (",
"    <a class=\"graphic graphic_table graphicRef83072 \" href=\"UTD.htm?27/8/27788\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/19,22,51\">",
"     19,22,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In all patients, therefore, it is important to obtain a detailed history of diabetes at diagnosis, including age, body mass index, and presenting symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/52\">",
"     52",
"    </a>",
"    ]. It is also important to ascertain insulin dependency and the presence or absence of family history of diabetes.",
"   </p>",
"   <p>",
"    In a patient with presumed type 1 diabetes, measurement of serum autoantibodies (islet-cell antibodies [ICA], glutamic acid decarboxylase [GAD65], insulin, tyrosine phosphatases, IA-2 and IA-2&beta;) should be performed prior to consideration of genetic testing for MODY. The presence of autoantibodies makes MODY very unlikely [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is more difficult to differentiate between MODY and type 2 diabetes mellitus. For patients with presumed type 2 diabetes, the presence of a simple (non-multigenerational) family history does not discriminate between MODY and type 2 diabetes. Insulin resistance is not a feature of MODY. Thus, diabetes in the absence of obesity is suspicious for MODY, particularly in adolescents with presumed type 2 diabetes. However, the absence of obesity or surrogate markers of insulin resistance is, in general, a poor discriminator of MODY and type 2 diabetes in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/19,52\">",
"     19,52",
"    </a>",
"    ]. There are currently no biochemical tests that reliably differentiate between the two diseases.",
"   </p>",
"   <p>",
"    For family members of mutation carriers, biochemical testing to confirm diabetes should be performed before genetic testing is considered [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/51\">",
"     51",
"    </a>",
"    ]. If the biochemical tests are consistent with a diagnosis of diabetes, genetic testing can be performed to confirm the diagnosis of a MODY mutation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38758?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnosis of diabetes mellitus\", section on 'Diagnostic criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Other beta-cell gene defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are other rare genetic defects in beta-cell function that are not considered part of the MODY spectrum. One type results from a dominantly inherited missense mutation in the sulfonylurea 1 receptor subunit (SUR1) that causes hyperinsulinemia in childhood, but beta-cell dysfunction and diabetes in adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3866?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of persistent hyperinsulinemic hypoglycemia of infancy\"",
"    </a>",
"    .) Other examples include point mutations in mitochondrial DNA [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/55\">",
"     55",
"    </a>",
"    ], genetic abnormalities that result in the inability to convert proinsulin to insulin [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/56\">",
"     56",
"    </a>",
"    ], and the production of mutant insulin molecules [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Genetic defects in insulin action",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a series of rare abnormalities in the insulin receptor (due to a genetic defect or the polycystic ovary syndrome) or in the structure of insulin itself. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28567?source=see_link\">",
"     \"Insulin resistance: Definition and clinical spectrum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Genetic defects in mitochondrial DNA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternally inherited diabetes and deafness (MIDD) is a rare mitochondrial disorder caused by a genetic mutation at position 3243 in transfer RNA [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Although phenotypic expression is variable, subjects universally have both a defect in insulin secretion, which progresses to insulin dependence, and sensorineural hearing loss. The mean age of onset of diabetes and hearing loss is between the ages of 30 and 40 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/59\">",
"     59",
"    </a>",
"    ]. Other abnormalities seen include cardiac conduction defects, gestational diabetes, proteinuria, and neuropathy.",
"   </p>",
"   <p>",
"    Although subjects may be treated with insulin secretagogues until insulin dependence develops,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    is less effective and carries a higher risk of lactic acidosis in this population [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/59\">",
"     59",
"    </a>",
"    ]. Supplementation with CoQ10 may be of some benefit. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=see_link&amp;anchor=H7#H7\">",
"     \"Metformin in the treatment of diabetes mellitus\", section on 'Lactic acidosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Wolfram syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the specific genetic defects described above, a number of rare genetic syndromes have been associated with diabetes. One example is the Wolfram or DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness) syndrome, originally described by Wolfram in 1938 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. This disorder is inherited as an autosomal recessive trait with incomplete penetrance.",
"   </p>",
"   <p>",
"    The gene responsible for the Wolfram syndrome, named WSF1, encodes an endoplasmic reticulum membrane-embedded protein called wolframin that is expressed in pancreatic beta cells and neurons [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/62-64\">",
"     62-64",
"    </a>",
"    ]. The estimated prevalence of Wolfram syndrome is 1 in 770,000 and it is believed to occur in 1 of 150 patients with type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Affected patients usually develop insulin-requiring diabetes and optic atrophy in early childhood, and diabetes insipidus as teenagers or young adults. The last problem is due to loss of vasopressin-secreting neurons in the supraoptic nucleus and impaired processing of vasopressin precursors [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21048?source=see_link\">",
"     \"Clinical manifestations and causes of central diabetes insipidus\"",
"    </a>",
"    .) Anterior pituitary dysfunction has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other manifestations of Wolfram syndrome include progressive sensorineural deafness, hydronephrosis (due in part to the high urine flow in diabetes insipidus), and neurologic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/66\">",
"     66",
"    </a>",
"    ]. Why severe insulin-requiring diabetes develops is not known; immunologic factors do not appear to be important [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DISEASES OF THE EXOCRINE PANCREAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any disease that damages the pancreas, or removal of pancreatic tissue, can result in diabetes. There is wide variability in the frequency with which this occurs, primarily determined by the degree of pancreatic insufficiency (",
"    <a class=\"graphic graphic_table graphicRef68883 \" href=\"UTD.htm?40/61/41947\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/67\">",
"     67",
"    </a>",
"    ]. Among patients with pancreatic exocrine disease, diabetes is more likely to occur in those with a family history of type 1 or type 2 diabetes. This observation suggests a role for an underlying decrease in pancreatic reserve or in insulin responsiveness that makes overt diabetes more likely in patients with pancreatic insufficiency.",
"   </p>",
"   <p>",
"    Diabetes that occurs in patients with pancreatic disease is usually insulin requiring. However, it is different from typical type 1 diabetes in that the pancreatic alpha cells, which produce glucagon, are also affected. As a result, there is an increased risk of hypoglycemia, both treatment-related and spontaneous.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Cystic fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanisms of cystic fibrosis related diabetes are unique and share features with both type 1 and type 2 diabetes, with both decreased insulin production and insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. Patients with no pancreatic exocrine deficiency have normal insulin secretion and responsiveness. In comparison, patients with exocrine deficiency have decreased insulin secretion, but normal glucose tolerance due to the unusual combination of increased hepatic glucose production and increased peripheral glucose utilization. How the latter adaptation occurs is unclear, but it is initially able to counteract the effects of insulin deficiency. Patients with exocrine deficiency and either impaired glucose tolerance or overt diabetes have reductions in both peripheral glucose utilization and hepatic insulin sensitivity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link&amp;anchor=H10#H10\">",
"     \"Cystic fibrosis: Nutritional issues\", section on 'CF-related diabetes mellitus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H22#H22\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'CF-related diabetes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Hereditary hemochromatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetes is common in patients with hereditary hemochromatosis, being present at diagnosis in up to 50 percent of symptomatic patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28617?source=see_link\">",
"     \"Clinical manifestations of hereditary hemochromatosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Chronic pancreatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucose intolerance occurs with some frequency in chronic pancreatitis, but overt diabetes mellitus usually occurs late in the course of disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/13/30935?source=see_link\">",
"     \"Clinical manifestations and diagnosis of chronic pancreatitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28616?source=see_link\">",
"     \"Clinical manifestations and diagnosis of chronic pancreatitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Fibrocalculous pancreatic diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibrocalculous pancreatic diabetes is a unique form of diabetes secondary to tropical pancreatitis that is endemic in certain parts of the world (eg, southern India). In a prospective evaluation of 370 patients, all of the macrovascular and microvascular complications typically associated with diabetes were found. Pancreatic cancer and complications of chronic pancreatitis also contribute to the mortality associated with this disease [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39575?source=see_link\">",
"     \"Etiology and pathogenesis of chronic pancreatitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Genetic linkages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both exocrine and endocrine pancreatic cells originate from the same endodermal pool. A genetic factor common to both endocrine and exocrine pancreatic development may account for some cases of pancreatic exocrine dysfunction with diabetes. Two Norwegian kindreds with an autosomal dominant inheritance pattern for diabetes and exocrine pancreatic dysfunction have been identified with a single-base deletion in the carboxyl ester lipase gene (CEL) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/71\">",
"     71",
"    </a>",
"    ]. The mechanism by which carboxyl ester lipase deficiency in pancreatic acinar cells is linked to beta cell failure is not known [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     ENDOCRINOPATHIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several hormones, such as epinephrine, glucagon, cortisol, and growth hormone, antagonize the action of insulin. Increased release of these hormones constitutes the protective counterregulatory response to hypoglycemia. On the other hand, primary oversecretion of these hormones can result in IFG or overt diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endocrine abnormalities that can lead to abnormalities in glucose regulation include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cushing's syndrome, due to pituitary or adrenal disease or to exogenous glucocorticoid administration (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=see_link\">",
"       \"Epidemiology and clinical manifestations of Cushing's syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Acromegaly (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30776?source=see_link\">",
"       \"Causes and clinical manifestations of acromegaly\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Catecholamine excess in pheochromocytoma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"       \"Clinical presentation and diagnosis of pheochromocytoma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Glucagon-secreting tumors (glucagonomas), associated with an unusual constellation of other clinical features, including skin rash, weight loss, anemia, and thromboembolic problems (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31640?source=see_link\">",
"       \"Glucagonoma and the glucagonoma syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Somatostatin-secreting tumors (somatostatinomas), typically associated with the triad of diabetes mellitus, cholelithiasis, and diarrhea with steatorrhea (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/34/3623?source=see_link\">",
"       \"Somatostatinoma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hyperthyroidism, which can interfere with glucose metabolism, although overt diabetes is unusual (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=see_link\">",
"       \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     DRUG-INDUCED DIABETES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large number of drugs can impair glucose tolerance; they act by decreasing insulin secretion, increasing hepatic glucose production, or causing resistance to the action of insulin (",
"    <a class=\"graphic graphic_table graphicRef67257 \" href=\"UTD.htm?10/40/10891\">",
"     table 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=see_link&amp;anchor=H36#H36\">",
"     \"Pathogenesis of type 2 diabetes mellitus\", section on 'Drug-induced hyperglycemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     VIRAL INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain viruses can cause diabetes, either through direct beta-cell destruction or, hypothetically, by inducing autoimmune damage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link\">",
"     \"Pathogenesis of type 1 diabetes mellitus\"",
"    </a>",
"    .) Chronic hepatitis C virus infection has been associated with an increased incidence of diabetes, but it is uncertain if there is a cause-and-effect relationship. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15498?source=see_link&amp;anchor=H5757471#H5757471\">",
"     \"Extrahepatic manifestations of hepatitis C virus infection\", section on 'Diabetes mellitus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     GESTATIONAL DIABETES MELLITUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gestational diabetes occurs when a woman's pancreatic function is not sufficient to overcome both the insulin resistance created by the anti-insulin hormones secreted by the placenta during pregnancy (eg, estrogen, prolactin, human chorionic somatomammotropin, cortisol, and progesterone) and the increased fuel consumption necessary to provide for the growing mother and fetus. It is estimated to occur in approximately 2.1 percent of pregnant women in the United States, usually developing in the second or third trimester. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9210?source=see_link\">",
"     \"Screening and diagnosis of diabetes mellitus during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     UNCOMMON IMMUNE-MEDIATED DIABETES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several uncommon forms of immune-mediated diabetes have been identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Stiff-person syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The stiff-person syndrome (formerly called stiff-man syndrome) is an autoimmune disorder of the central nervous system, which is characterized by progressive muscle stiffness, rigidity, and spasm involving the axial muscles, with severe impairment of ambulation. Patients usually have high titers of anti-GAD antibodies, and diabetes occurs in approximately one-third of cases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/41/665?source=see_link\">",
"     \"Stiff-person syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Anti-insulin receptor antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anti-insulin receptor antibodies can bind to insulin receptors and either act as an agonist, leading to hypoglycemia, or block the binding of insulin and cause diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/33/14874/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/43/692?source=see_link\">",
"       \"Patient information: Type 1 diabetes (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=see_link\">",
"       \"Patient information: Type 2 diabetes (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/26/36259?source=see_link\">",
"       \"Patient information: Diabetes mellitus type 1: Overview (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/22/9572?source=see_link\">",
"       \"Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type 1 diabetes is characterized by destruction of the pancreatic beta cells, leading to absolute insulin deficiency. This is usually due to autoimmune destruction of the pancreatic beta cells. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Type 1 diabetes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Type 2 diabetes is by far the most common type of diabetes, and is characterized by variable degrees of insulin deficiency and resistance. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Type 2 diabetes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is occasionally difficult to distinguish between type 1 and atypical presentations of type 2 diabetes. We often measure autoantibodies (GAD65, insulin, tyrosine phosphatases [IA-2 and IA-2&beta;], islet cell) when the diagnosis of type 1 or type 2 diabetes is uncertain by clinical presentation (ie, thin patient with poor response to initial therapy with sulfonylureas or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      , personal or family history of autoimmune disease). If one or more of the antibodies is present, and especially if two or more are positive, the patient should be presumed to have type 1 diabetes and should be treated with insulin replacement therapy, as these patients respond poorly to diet and oral hypoglycemic drug therapy. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Distinguishing type 1 from type 2 diabetes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As the human genome is further explored, it is likely that multiple genetic anomalies at different loci will be found that confer varying degrees of predisposition to type 1 and type 2 diabetes. Monogenic causes of type 2 diabetes represent only a small fraction of cases and commonly inherited polymorphisms individually contribute only small degrees of risk for, or protection from, diabetes. Most of the genetic risk for type 2 diabetes results from complex polygenic risk factors. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Genetic defects'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=see_link&amp;anchor=H8#H8\">",
"       \"Pathogenesis of type 2 diabetes mellitus\", section on 'Genetic susceptibility'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Maturity onset diabetes of the young (MODY) is a clinically heterogeneous disorder characterized by non-insulin dependent diabetes diagnosed at a young age (&lt;25 years) with autosomal dominant transmission and lack of autoantibodies. It is classified by the underlying genetic defect (",
"      <a class=\"graphic graphic_table graphicRef83071 \" href=\"UTD.htm?36/32/37388\">",
"       table 2",
"      </a>",
"      ). Many patients with MODY are misclassified as having either type 1 or 2 diabetes. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Maturity onset diabetes of the young'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of MODY is made by performing diagnostic genetic testing by direct sequencing of the gene. Laboratories in several countries offer clinical testing, primarily for mutations in HNF4A, HNF1A, and the glucokinase gene. (See",
"      <a class=\"local\" href=\"#H3754064\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      We typically perform genetic testing for MODY when there is a high index of suspicion (familial diabetes with autosomal dominant pattern of inheritance (&gt;2 generations), onset &lt;25 years, non obese, negative islet autoantibodies) (",
"      <a class=\"graphic graphic_table graphicRef83072 \" href=\"UTD.htm?27/8/27788\">",
"       table 3",
"      </a>",
"      ). For family members of mutation carriers, biochemical testing to confirm diabetes should be performed before genetic testing is considered. If the biochemical tests are consistent with a diagnosis of diabetes, genetic testing can be performed to confirm the diagnosis of a MODY mutation. (See",
"      <a class=\"local\" href=\"#H4885959\">",
"       'Indications for genetic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diseases that damage the pancreas, or removal of pancreatic tissue, can result in diabetes. There is wide variability in the frequency with which this occurs, primarily determined by the degree of pancreatic insufficiency (",
"      <a class=\"graphic graphic_table graphicRef68883 \" href=\"UTD.htm?40/61/41947\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Diseases of the exocrine pancreas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several endocrinopathies, including Cushing's syndrome, acromegaly, and pheochromocytoma, can lead to abnormalities in glucose regulation. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Endocrinopathies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A large number of drugs can impair glucose tolerance; they act by decreasing insulin secretion, increasing hepatic glucose production, or causing resistance to the action of insulin (",
"      <a class=\"graphic graphic_table graphicRef67257 \" href=\"UTD.htm?10/40/10891\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=see_link&amp;anchor=H36#H36\">",
"       \"Pathogenesis of type 2 diabetes mellitus\", section on 'Drug-induced hyperglycemia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/1\">",
"      American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34 Suppl 1:S62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/2\">",
"      Harris MI, Robbins DC. Prevalence of adult-onset IDDM in the U.S. population. Diabetes Care 1994; 17:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/3\">",
"      Landin-Olsson M, Nilsson KO, Lernmark A, Sundkvist G. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 1990; 33:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/4\">",
"      Niskanen LK, Tuomi T, Karjalainen J, et al. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 1995; 18:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/5\">",
"      Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/6\">",
"      Leslie RD, Williams R, Pozzilli P. Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab 2006; 91:1654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/7\">",
"      Naik RG, Brooks-Worrell BM, Palmer JP. Latent autoimmune diabetes in adults. J Clin Endocrinol Metab 2009; 94:4635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/8\">",
"      Cervin C, Lyssenko V, Bakhtadze E, et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 2008; 57:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/9\">",
"      Lukacs K, Hosszufalusi N, Dinya E, et al. The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia 2012; 55:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/10\">",
"      Pettersen E, Skorpen F, Kval&oslash;y K, et al. Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Tr&oslash;ndelag Health Study. Diabetes 2010; 59:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/11\">",
"      Maruyama T, Nakagawa T, Kasuga A, Murata M. Heterogeneity among patients with latent autoimmune diabetes in adults. Diabetes Metab Res Rev 2011; 27:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/12\">",
"      Falorni A, Gambelunghe G, Forini F, et al. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 2000; 85:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/13\">",
"      Borg H, Gotts&auml;ter A, Landin-Olsson M, et al. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age. J Clin Endocrinol Metab 2001; 86:3032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/14\">",
"      Purnell JQ, Dev RK, Steffes MW, et al. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial. Diabetes 2003; 52:2623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/15\">",
"      Fourlanos S, Perry C, Stein MS, et al. A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care 2006; 29:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/16\">",
"      Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 1975; 24:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/17\">",
"      Gat-Yablonski G, Shalitin S, Phillip M. Maturity onset diabetes of the young--review. Pediatr Endocrinol Rev 2006; 3 Suppl 3:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/18\">",
"      McDonald TJ, Colclough K, Brown R, et al. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. Diabet Med 2011; 28:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/19\">",
"      Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ 2011; 343:d6044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/20\">",
"      Dussoix P, Vaxillaire M, Iynedjian PB, et al. Diagnostic heterogeneity of diabetes in lean young adults: classification based on immunological and genetic parameters. Diabetes 1997; 46:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/21\">",
"      Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/22\">",
"      Naylor R, Philipson LH. Who should have genetic testing for maturity-onset diabetes of the young? Clin Endocrinol (Oxf) 2011; 75:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/23\">",
"      Shields BM, Hicks S, Shepherd MH, et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 2010; 53:2504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/24\">",
"      Yamagata K, Furuta H, Oda N, et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/25\">",
"      Herman WH, Fajans SS, Ortiz FJ, et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 1994; 43:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/26\">",
"      Lindner T, Gragnoli C, Furuta H, et al. Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene. J Clin Invest 1997; 100:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/27\">",
"      Gupta RK, Vatamaniuk MZ, Lee CS, et al. The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. J Clin Invest 2005; 115:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/28\">",
"      Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993; 328:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/29\">",
"      Kesavan P, Wang L, Davis E, et al. Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2). Biochem J 1997; 322 ( Pt 1):57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/30\">",
"      Velho G, Blanch&eacute; H, Vaxillaire M, et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997; 40:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/31\">",
"      Chiu KC, Province MA, Permutt MA. Glucokinase gene is genetic marker for NIDDM in American blacks. Diabetes 1992; 41:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/32\">",
"      Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996; 384:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/33\">",
"      Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 1996; 276:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/34\">",
"      Hansen T, Eiberg H, Rouard M, et al. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes 1997; 46:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/35\">",
"      Stride A, Ellard S, Clark P, et al. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care 2005; 28:1751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/36\">",
"      Pearson ER, Starkey BJ, Powell RJ, et al. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003; 362:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/37\">",
"      Shepherd M, Shields B, Ellard S, et al. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 2009; 26:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/38\">",
"      Steele AM, Shields BM, Shepherd M, et al. Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. Diabet Med 2010; 27:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/39\">",
"      Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997; 17:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/40\">",
"      Macfarlane WM, Frayling TM, Ellard S, et al. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 1999; 104:R33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/41\">",
"      Hart AW, Baeza N, Apelqvist A, Edlund H. Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature 2000; 408:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/42\">",
"      Hani EH, Stoffers DA, Ch&egrave;vre JC, et al. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 1999; 104:R41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/43\">",
"      Weng J, Macfarlane WM, Lehto M, et al. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations. Diabetologia 2001; 44:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/44\">",
"      Horikawa Y, Iwasaki N, Hara M, et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 1997; 17:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/45\">",
"      Bellann&eacute;-Chantelot C, Chauveau D, Gautier JF, et al. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 2004; 140:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/46\">",
"      Woolf AS, Feather SA, Bingham C. Recent insights into kidney diseases associated with glomerular cysts. Pediatr Nephrol 2002; 17:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/47\">",
"      Hiesberger T, Bai Y, Shao X, et al. Mutation of hepatocyte nuclear factor-1beta inhibits Pkhd1 gene expression and produces renal cysts in mice. J Clin Invest 2004; 113:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/48\">",
"      Bingham C, Ellard S, van't Hoff WG, et al. Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutation. Kidney Int 2003; 63:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/49\">",
"      Malecki MT, Jhala US, Antonellis A, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999; 23:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/50\">",
"      Kristinsson SY, Thorolfsdottir ET, Talseth B, et al. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. Diabetologia 2001; 44:2098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/51\">",
"      Ellard S, Bellann&eacute;-Chantelot C, Hattersley AT, European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008; 51:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/52\">",
"      Bellann&eacute;-Chantelot C, L&eacute;vy DJ, Carette C, et al. Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene. J Clin Endocrinol Metab 2011; 96:E1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/53\">",
"      Huopio H, Reimann F, Ashfield R, et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest 2000; 106:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/54\">",
"      Huopio H, Otonkoski T, Vauhkonen I, et al. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet 2003; 361:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/55\">",
"      Johns DR. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. N Engl J Med 1995; 333:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/56\">",
"      Robbins DC, Shoelson SE, Rubenstein AH, Tager HS. Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion. J Clin Invest 1984; 73:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/57\">",
"      Tager H, Given B, Baldwin D, et al. A structurally abnormal insulin causing human diabetes. Nature 1979; 281:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/58\">",
"      Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994; 330:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/59\">",
"      Donovan LE, Severin NE. Maternally inherited diabetes and deafness in a North American kindred: tips for making the diagnosis and review of unique management issues. J Clin Endocrinol Metab 2006; 91:4737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/60\">",
"      Cremers CW, Wijdeveld PG, Pinckers AJ. Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome). A review of 88 cases from the literature with personal observations on 3 new patients. Acta Paediatr Scand Suppl 1977; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/61\">",
"      Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995; 346:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/62\">",
"      Inoue H, Tanizawa Y, Wasson J, et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 1998; 20:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/63\">",
"      Strom TM, H&ouml;rtnagel K, Hofmann S, et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 1998; 7:2021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/64\">",
"      Boutzios G, Livadas S, Marinakis E, et al. Endocrine and metabolic aspects of the Wolfram syndrome. Endocrine 2011; 40:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/65\">",
"      Gabre&euml;ls BA, Swaab DF, de Kleijn DP, et al. The vasopressin precursor is not processed in the hypothalamus of Wolfram syndrome patients with diabetes insipidus: evidence for the involvement of PC2 and 7B2. J Clin Endocrinol Metab 1998; 83:4026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/66\">",
"      Chaussenot A, Bannwarth S, Rouzier C, et al. Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Ann Neurol 2011; 69:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/67\">",
"      Del Prato S, Tiengo A. Pancreatic diabetes. Diabetes Reviews 1993; 1:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/68\">",
"      Moran A, Pyzdrowski KL, Weinreb J, et al. Insulin sensitivity in cystic fibrosis. Diabetes 1994; 43:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/69\">",
"      O'Riordan SM, Robinson PD, Donaghue KC, Moran A. Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes 2009; 10 Suppl 12:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/70\">",
"      Mohan V, Premalatha G, Padma A, et al. Fibrocalculous pancreatic diabetes. Long-term survival analysis. Diabetes Care 1996; 19:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/71\">",
"      Raeder H, Johansson S, Holm PI, et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 2006; 38:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/72\">",
"      Hattersley AT. Beyond the beta cell in diabetes. Nat Genet 2006; 38:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/33/14874/abstract/73\">",
"      Taylor SI. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 1992; 41:1473.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1793 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-125.39.66.150-851E2265C2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14874=[""].join("\n");
var outline_f14_33_14874=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H34\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TYPE 1 DIABETES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H247196672\">",
"      Latent autoimmune diabetes in adults (LADA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TYPE 2 DIABETES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H270106199\">",
"      DKA in type 2 diabetes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DISTINGUISHING TYPE 1 FROM TYPE 2 DIABETES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      GENETIC DEFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Maturity onset diabetes of the young",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Hepatocyte nuclear factor-4-alpha",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Glucokinase gene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Hepatocyte nuclear factor-1-alpha",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Insulin promoter factor 1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Hepatocyte nuclear factor-1-beta",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Neurogenic differentiation factor-1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3753980\">",
"      - Other genes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3754064\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4885959\">",
"      - Indications for genetic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other beta-cell gene defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Genetic defects in insulin action",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Genetic defects in mitochondrial DNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Wolfram syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DISEASES OF THE EXOCRINE PANCREAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Chronic pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Fibrocalculous pancreatic diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Genetic linkages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      ENDOCRINOPATHIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      DRUG-INDUCED DIABETES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      VIRAL INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      GESTATIONAL DIABETES MELLITUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      UNCOMMON IMMUNE-MEDIATED DIABETES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Stiff-person syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Anti-insulin receptor antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/1793\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/1793|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/22/42349\" title=\"table 1\">",
"      ADA classification DM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/32/37388\" title=\"table 2\">",
"      MODY common gene mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/8/27788\" title=\"table 3\">",
"      Clinical features distinguishing T1DM T2DM MODY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/61/41947\" title=\"table 4\">",
"      Pancreatic diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/40/10891\" title=\"table 5\">",
"      Drug induced diabetes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29913?source=related_link\">",
"      Autosomal recessive polycystic kidney disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30776?source=related_link\">",
"      Causes and clinical manifestations of acromegaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/41/15000?source=related_link\">",
"      Causes of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21048?source=related_link\">",
"      Clinical manifestations and causes of central diabetes insipidus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/13/30935?source=related_link\">",
"      Clinical manifestations and diagnosis of chronic pancreatitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28616?source=related_link\">",
"      Clinical manifestations and diagnosis of chronic pancreatitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28617?source=related_link\">",
"      Clinical manifestations of hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=related_link\">",
"      Cystic fibrosis: Nutritional issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=related_link\">",
"      Cystic fibrosis: Overview of gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38758?source=related_link\">",
"      Diagnosis of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=related_link\">",
"      Epidemiology and clinical manifestations of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39575?source=related_link\">",
"      Etiology and pathogenesis of chronic pancreatitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15498?source=related_link\">",
"      Extrahepatic manifestations of hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=related_link\">",
"      Genetic counseling and testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31640?source=related_link\">",
"      Glucagonoma and the glucagonoma syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28567?source=related_link\">",
"      Insulin resistance: Definition and clinical spectrum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41702?source=related_link\">",
"      Insulin secretion and pancreatic beta-cell function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/20/24906?source=related_link\">",
"      Insulin therapy in adults with type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/24/30089?source=related_link\">",
"      Insulin therapy in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=related_link\">",
"      Metformin in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37816?source=related_link\">",
"      Neonatal hyperglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=related_link\">",
"      Overview of the clinical manifestations of hyperthyroidism in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=related_link\">",
"      Pathogenesis of type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=related_link\">",
"      Pathogenesis of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3866?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of persistent hyperinsulinemic hypoglycemia of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/26/36259?source=related_link\">",
"      Patient information: Diabetes mellitus type 1: Overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/22/9572?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/43/692?source=related_link\">",
"      Patient information: Type 1 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=related_link\">",
"      Patient information: Type 2 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=related_link\">",
"      Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/41/2712?source=related_link\">",
"      Renal cystic diseases in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10935?source=related_link\">",
"      Renal hypoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9210?source=related_link\">",
"      Screening and diagnosis of diabetes mellitus during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/34/3623?source=related_link\">",
"      Somatostatinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/41/665?source=related_link\">",
"      Stiff-person syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32920?source=related_link\">",
"      Syndromes of ketosis-prone diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=related_link\">",
"      Uric acid renal diseases",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_33_14875="Discharge plan PI";
var content_f14_33_14875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F60053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F60053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    What a discharge plan should include",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        When you leave the hospital, the staff should give you:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A written description of why you were in the hospital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A written list of all the medicines you are supposed to take, and instructions on how to take them and how to get them",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Written instructions on what to do if your condition changes or you have warning signs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Written details about all the medical appointments you have after you leave the hospital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Written instructions on how to get the results of any tests that were done that have not yet come back by the time you leave the hospital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The contact information for a staff member at the hospital who can answer your questions",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: the Components of Re-Engineered Discharge. Available at:",
"     <a href=\"https://www.bu.edu/fammed/projectred/components.html\" target=\"_blank\">",
"      https://www.bu.edu/fammed/projectred/components.html",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14875=[""].join("\n");
var outline_f14_33_14875=null;
var title_f14_33_14876="JE vaccine recommendations";
var content_f14_33_14876=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for use of JE vaccine in travelers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Recommendations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Japanese encephalitis (JE) vaccine is recommended for travelers who plan to spend a month or longer in endemic areas during the JE virus (JEV) transmission season. This includes long-term travelers, recurrent travelers, or expatriates who will be based in urban areas but are likely to visit endemic rural or agricultural areas during a high risk period of JEV transmission.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        JE vaccine should be considered for the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Short-term travelers (&lt;1 month) to endemic areas during the JEV transmission season if they plan to travel outside of an urban area and have an increased risk of JEV exposure. Examples of higher risk activities or itineraries include: 1) Spending substantial time outdoors in rural or agricultural areas, especially during the evening or night; 2) Participating in extensive outdoor activities (eg, camping, hiking, trekking, biking, fishing, hunting, or farming); and 3) Staying in accommodations without air conditioning, screens, or bed nets.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Travelers to an area with an ongoing JE outbreak",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Travelers to endemic areas who are uncertain of specific destinations, activities, or duration of travel",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        JE vaccine is not recommended for short-term travelers whose visit will be restricted to urban areas or times outside of a well-defined JEV transmission season.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Information on expected JEV transmission by country can be obtained from CDC at",
"        <a href=\"file://www.cdc.gov/travel/yellowBookCh4-JapaneseEncephalitis.aspx\" target=\"_blank\">",
"         file://www.cdc.gov/travel/yellowBookCh4-JapaneseEncephalitis.aspx",
"        </a>",
"        . These data should be interpreted cautiously since JEV transmission activity varies within countries and from year to year.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        JE vaccine is also recommended for laboratory personnel with potential for exposure to infectious JE virus. Vaccinated, at-risk laboratory personnel should receive appropriate booster doses of JE vaccine or be evaluated regularly for JEV-specific neutralizing antibodies to assure adequate titers.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14876=[""].join("\n");
var outline_f14_33_14876=null;
var title_f14_33_14877="Causes S2 abnormalities";
var content_f14_33_14877=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Abnormalities of the second heart sound (S2) and their mechanisms",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Wide splitting of S2 with maintained inspiratory delay of P2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Delayed activation and completion of right ventricular ejection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Complete right bundle branch block",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Artificial left ventricular pacing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pre-excitation of the left ventricle (Wolff-Parkinson-White syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Premature beats and idioventricular rhythm originating from the left ventricle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Prolonged right ventricular ejection time",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pulmonary hypertension with right heart failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Right ventricular outflow obstruction (eg, pulmonic stenosis, acute massive pulmonary embolus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Increased pulmonary hangout time",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Idiopathic dilatation of the pulmonary artery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mild pulmonic stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Postoperative atrial septal defect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Decreased left ventricular ejection time (early A2)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mitral regurgitation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ventricular septal defect with low pulmonary vascular resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Constrictive pericarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Fixed splitting of S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unchanged right ventricular stroke volume during respiration; severe right ventricular failure due to any cause",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interatrial communication; atrial septal defect; common atrium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Reversed splitting of S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Delayed left ventricular activation and completion of ejection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Left bundle branch block",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Artificial right ventricular pacing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pre-excitation of the right ventricle (Wolff-Parkinson-White syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Premature beats of right ventricular origin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Prolonged left ventricular ejection time",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Increased resistance to left ventricular ejection (aortic stenosis, obstructive hypertrophic cardiomyopathy, hypertension)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Isolated increase in left ventricular forward stroke volume (aortic regurgitation, patent ductus arteriosus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myocardial dysfunction (mild to moderate left ventricular failure, myocardial ischemia or infarction)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Increased aortic hangout time (not the sole cause)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aortic regurgitation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Patent ductus arteriosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aortic stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Single S2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Apparent:",
"        </strong>",
"        obesity, emphysema, pericardial effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Absent A2:",
"        </strong>",
"        severe aortic stenosis, severe aortic regurgitation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Absent P2:",
"        </strong>",
"        absent pulmonary valve, pulmonary atresia, tetralogy of Fallot, truncus arteriosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Fusion of A2 and P2:",
"        </strong>",
"        Eisenmenger's ventricular septal defect, common ventricle",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14877=[""].join("\n");
var outline_f14_33_14877=null;
var title_f14_33_14878="Plasma NEP asx LV dysfunction";
var content_f14_33_14878=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 519px\">",
"   <div class=\"ttl\">",
"    Plasma norepinephrine predicts outcome in patients with asymptomatic left ventricular dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 499px; height: 223px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the SOLVD trial of patients with asymptomatic left ventricular dysfunction, mostly following myocardial infarction, plasma norepinephrine concentrations (PNe) above the median were associated with significant increases in cardiovascular mortality (left panel, p = 0.003) and all-cause mortality or hospitalization for heart failure (right panel, p &lt;0.001).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Benedict CR, Shelton B, Johnstone DE, et al. Circulation 1996; 94:690.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14878=[""].join("\n");
var outline_f14_33_14878=null;
var title_f14_33_14879="Indeterminate thyroid nodule scan II";
var content_f14_33_14879=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F51029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F51029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Indeterminate thyroid scan: Appearance on thyroid scintigraphy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 339px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    123-I thyroid scan obtained to assess a palpable right thyroid nodule. The function of the nodule could not be determined.",
"    <div class=\"footnotes\">",
"     SSN: suprasternal notch.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Douglas Ross, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_33_14879=[""].join("\n");
var outline_f14_33_14879=null;
